Susan K Peterson, Ph.D., M.P.H.

Department of Behavioral Science, Division of Cancer Prevention and Population Sciences

Present Title & Affiliation

Primary Appointment

Ad Interim Chair, Behavioral Science, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas

Associate Member, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX

Professor, Department of Behavioral Science, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Member, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX

Dual/Joint/Adjunct Appointment

Adjunct Professor, Division of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX

Education & Training

Degree-Granting Education

2001	The University of Texas Health Science Center at Houston School of Public Health, Houston, Texas, US, Behavioral Sciences, Ph.D
1986	The University of Michigan School of Public Health, Ann Arbor, Michigan, US, Health Behavior and Health Education, MPH
1984	The University of Michigan, Ann Arbor, Michigan, US, Anthropology and Zoology, BS

Experience & Service

Faculty Academic Appointments

Associate Professor, Department of Behavioral Science, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014

Adjunct Associate Professor, Division of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, 2008 - 2014

Member, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 2006 - 2024

Adjunct Assistant Professor, Division of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, 2005 - 2008

Associate Member, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 2002 - 2006

Administrative Appointments/Responsibilities

Deputy Department Chair, Department of Behavioral Science, The University of Houston MD Anderson Cancer Center, Houston, Texas, 2020 - Present

Director, Assessment, Intervention and Measurement Shared Resource, Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2015 - Present

Associate Director, Office of Women and Minority Faculty Inclusion, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2018

Assistant Professor, Behavioral Science, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2002 - 2008

Other Professional Positions

Co-Chair, Behavioral Working Group, Colon Cancer Family Registries, National Cancer Institute, National Institutes of Health, Bethesda, MD, 2011 - 2012

Member, Advisory Committee, Genetics for Social and Behavioral Science Researchers, National Coalition on Healthcare Professional Education in Genetics (NCHPEG), Lutherville, MD, 2009 - 2012

Member, Behavioral Working Group, Colon Cancer Family Registries, National Cancer Institute, National Institutes of Health, Bethesda, MD, 2005 - 2012

Research Manager, The University of Texas MD Anderson Cancer Center, Houston, TX, 1995 - 2002

Member, Cancer Patient Education Standards Task Force, National Cancer Institute, Bethesda, MD, 1992 - 1993

Assistant Director, Patient Education Office, The University of Texas MD Anderson Cancer Center, Houston, TX, 1990 - 1995

Technical Resource Consultant, Advisory Council on Breast Cancer Treatment Alternatives, Texas Department of Health, Austin, TX, 1990 - 1991

Health Education Coordinator, The University of Texas MD Anderson Cancer Center, Houston, TX, 1987 - 1990

Research Scientist, New Jersey Department of Health, Trenton, NJ, 1986 - 1987

Intramural Institutional Committee Activities

Chair, Population/Quantitative Science Review Panel, Andrew Sabin Fellowship Award, The University of Texas MD Anderson Cancer Center, 2023 - Present

Member, Department of Plastic Surgery Chair Search Committee, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2023 - 2024

Co-Chair, Population/Quantitative Science Review Panel, Andrew Sabin Fellowship Award, The University of Texas MD Anderson Cancer Center, 2022 - 2023

Chair, Scientific Review Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2025

Co-Chair, Cancer Survivorship Research Advisory Workgroup, Office of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, 2021 - Present

Member, Promotion and Tenure Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2025

Member, Patient Survey Governance Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2025

Member, Executive Scientific Review Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2025

Member, Adolescent and Young Adult Research Program, The University of Texas MD Anderson Cancer Center, 2017 - Present

Member, Cancer Survivorship Research Advisory Workgroup, Office of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, 2014 - 2021

Member, Clinical Cancer Genetics Steering Committee, The University of Texas MD Anderson Cancer Center, 2005 - Present

Extramural Institutional Committee Activities

Member, Faculty Search Committee, Center for Energy Balance in Survivorship & Prevention, The University of Texas MD Anderson Cancer Center, 2018

Chair, Trainee Research Day, Population Science Oral Presentations Sessions, The University of Texas MD Anderson Cancer Center, 2016

Chair, Mid-tenure Review Committee for Jason Robinson, PhD, The University of Texas MD Anderson Cancer Center, 2016

Member, Search Committee, Chair of Department of Health Disparities, The University of Texas MD Anderson Cancer Center, 2015 - 2016

Member, Faculty Search Committee, Department of Health Disparities, The University of Texas MD Anderson Cancer Center, 2015 - 2016

Member, Oncologic Emergency Medicine Conference, The University of Texas MD Anderson Cancer Center, 2015

Member, Mobile Computing Workgroup, The University of Texas MD Anderson Cancer Center, 2014 - 2015

Member, Assistant Professor Mid-Progress Review Committee for Eileen Shinn, Ph.D, The University of Texas MD Anderson Cancer Center, 2014

Member, Business Planning Working Group, Adolescent and Young Adult Program, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, 2014

Abstract Reviewer, Trainee Research Day, The University of Texas MD Anderson Cancer Center, 2014

Member, Advisory Committee, Cancer Prevention Research Training Program, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, 2013

Member, Division Council on Gender Inclusiveness, Women and Minority Faculty Inclusion, The University of Texas MD Anderson Cancer Center, 2013

Co-Chair, Division Council on Gender Inclusiveness, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, 2013

Faculty Search Committee, Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, 2012 - 2013

Planning Committee Member, Road to Professor and Beyond: A Workshop for Women Associate Professors at MD Anderson Cancer Center, Women Faculty Programs, The University of Texas MD Anderson Cancer Center, 2012 - 2013

Member, Mid-tenure track review committee for Damon Vidrine, DrPH, The University of Texas MD Anderson Cancer Center, 2012

Member, Instructor mid-progress review committee for Mary Tripp, PhD, MPH, The University of Texas MD Anderson Cancer Center, 2012

Member, Comprehensive Cancer Control Survivorship Working Group, The University of Texas MD Anderson Cancer Center, 2012

Judge, Trainee Research Day Poster Competition and Trainee Choice Award, The University of Texas MD Anderson Cancer Center, 2011 - 2013

Chair, Early Career Development Program Planning Committee, Women Faculty Programs, The University of Texas MD Anderson Cancer Center, 2011 - 2012

Member, Odyssey Program Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011

Member, Mid-tenure track review committee for Lorraine Reitzel, Ph.D, The University of Texas MD Anderson Cancer Center, 2011

Member, Institutional Research Grant Review Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2013

Member, Psychosocial, Behavioral and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2013

Member, The Division of Cancer Prevention & Population Sciences Charles A. LeMaistre Lectureship Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011

Member, Comprehensive Cancer Control Colorectal Cancer Working Group, The University of Texas MD Anderson Cancer Center, 2010

Member, Duncan Family Institute Premalignant Genome Atlas Program, Steering Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2016

Assistant Professor, Mid progress review committee for Ludmila Cofta-Woerpel, Ph.D, The University of Texas MD Anderson Cancer Center, 2009

Member, Duncan Family Institute e-Health Technology Program Advisory Board, The University of Texas MD Anderson Cancer Center, 2009

Member, American Cancer Society Institutional Research Grant Review Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2009

Associate Member, Institutional Review Board 4, The University of Texas MD Anderson Cancer Center, 2007 - 2011

Chair, Psychosocial, Behavioral and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2010

Member, I*Care Advisory Committee, The University of Texas MD Anderson Cancer Center, 2007

Member, External Review Committee, Pediatric Education Program, Section of Behavioral Medicine, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, 2006

Member, Human Pedigree Analysis Core Advisory Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2012

Member, Psychosocial, Behavioral and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2006

Behavioral Science Department Representative, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2002 - 2005

Editorial Activities

Editorial Review Board, Cancer Medicine, 2012 - 2013

Guest Editorial Board, Special Issue on The Challenge Ahead: Implications of Genomics for Health Behavior and Health Education, Health Education and Behavior, 2005

Guest Editorial Board, Theme Issue on Communicating Environmental Risk, Health Education and Behavior, 1991

Honors & Awards

2022	Inaugural Fellowship Class, Collaborative Group of the Americas on Inherited Gastrointestinal Cancers
2021	Distinguished Mentor Award, MD Anderson Cancer Center
2020	Finalist, Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center
2016	Real. Strong. Women of Distinction Award, Alpha Chi Omega
2014	Faculty Leadership Academy, MD Anderson Cancer Center
2012	Finalist, Robert M. Chamberlain Distinguished Mentor Award, MD Anderson Cancer Center
2011	Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center
2011	Faculty Educator of the Month, November, MD Anderson Cancer Center
2010	Mid-Career Women Faculty Professional Development Seminar, Association of American Medical Colleges
2010	National Institutes of Health Merit Award (Group Award), PDQ Cancer Genetics Editorial Board
2007	Social and Behavioral Research Branch Inaugural Forum, National Human Genome Research Institute, National Institutes of Health
2006	Heart of Leadership Faculty Development Program, MD Anderson Cancer Center
2004	Fellow, Summer Institute on the Design and Conduct of Randomized Clinical Trials Involving Behavioral Interventions, Office of Behavioral and Social Sciences Research, National Institutes of Health
2004	Fellow, Cancer, Culture and Literacy Institute, H. Lee Moffitt Cancer Center, Tampa FL
1998	Conference Scholarship, Behavioral Science and Cancer Genetics: New Roles, New Partners, American Psychological Association
1995	First Place, Patient Education Category, Health Sciences Communication Association Interactive Media Festival
1992	Award for Outstanding Leadership in Cancer Patient Education, National Cancer Institute
1989	First Place, Patient Education Category, American Society for Healthcare Education and Training Film Festival
1985	Internship, Air Products and Chemicals, Inc
1984 - 1986	Student Traineeship, U.S. Public Health Service

Professional Memberships

International Society for Hereditary Gastrointestinal Tumours

2007 - 2011

Collaborative Group of the Americas on Inherited Colorectal Cancer

2005 - Present

Selected Presentations & Talks

Formal Peers

2015. Integrating Technology for Behavioral Assessment and Intervention for Cancer Prevention and. Invited. Lexington, US.
2014. CYCORE: Cyberinfrastructure for Cancer Comparative Effectiveness Research. Invited. San Diego, CA, US.
2014. Using Home-Based Mobile Sensors for Remote Monitoring in Cancer Care and Prevention. Invited. Galveston, TX, US.
2010. Keynote Speaker: Living with Lynch syndrome. Invited. Rochester, MN, US.
2010. E-health interventions for hereditary cancer families. Medical Genetics Research Forum. Invited. Rochester, MN, US.
2002. Psychosocial Issues Influencing Women's Decisions to Have Genetic Testing for Inherited Breast and Ovarian Cancer. Invited. College Station, TX, US.

Less

Grant & Contract Support

Date:	2027 - 2029
Title:	Patient-centered prediction of long-term quality of life after endocrine treatment for early breast cancer: combining breast biology and machine learning
Funding Source:	DOD
Role:	Co-I

Date:	2027 - 2029
Title:	Patient-centered prediction of long-term quality of life after endocrine treatment for early breast cancer: combining breast biology and machine learning
Funding Source:	US Department of Defense
Role:	Co-I
ID:	BC261116

Date:	2026 - 2030
Title:	HEALTH4Families: A weight management and health behavior intervention for families with genetic predisposition to cancer
Funding Source:	CPRIT
Role:	PI
ID:	RP270303

Date:	2026 - 2030
Title:	Multi-Institutional Validation and Dissemination of LFSPRO2.0: A Scalable Risk Prediction Tool for Li Fraumeni Syndrome Across Academic and Community Settings
Funding Source:	CPRIT
Role:	Co-I
ID:	RP210560

Date:	2026 - 2029
Title:	Predicting patient-specific quality of life via machine learning and understanding patient preferences for personalized treatment in low-risk ER+ breast cancer
Funding Source:	CANCER PREVENTION RESEARCH INSTITUTE OF TX (CPRIT)
Role:	Co-I
ID:	RP270472

Date:	2026 - 2029
Title:	Health4Families: A weight management intervention for families with genetic predisposition to cancer
Funding Source:	CPRIT
Role:	Co-I

Date:	2026 - 2031
Title:	HEALTH4Families: A weight management and health behavior intervention for families with genetic predisposition to cancer
Funding Source:	NIH
Role:	PI
ID:	1R01CA319152-01

Date:	2026 - 2031
Title:	The University of Texas MD Anderson Cancer Center Support Grant (CCSG)
Funding Source:	nih/nci
Role:	Other
ID:	2P30CA016672-50

Date:	2026 - 2031
Title:	Cancer Center Support (CORE) Grant
Funding Source:	NCI
Role:	Other
ID:	P30CA016672-50

Date:	2026 - 2028
Title:	A comprehensive approach to inform the use of remote patient monitoring for improving advanced cancer outcomes in Puerto Rico
Funding Source:	NIH
Role:	PI
ID:	FP00026608

Date:	2026 - 2031
Title:	AYA LASSO: A statewide platform to assess and improve long-term health outcomes in AYA cancer survivors
Funding Source:	CPRIT
Role:	Co-PI
ID:	RP260740

Date:	2025 - 2026
Title:	Patient-centered prediction of long-term quality of life after endocrine treatment for early breast cancer: combining breast biology and machine learning
Funding Source:	US Department of Defense
Role:	Co-PI
ID:	BC251303

Date:	2025 - 2030
Title:	UPR/MDACC Partnership for Excellence in Cancer Research
Funding Source:	NIH
Role:	Key
ID:	2U54CA096300-21A1

Date:	2025 - 2030
Title:	Identifying multidimensional physical function features most predictive of clinical outcomes in adolescents and young adults with cancer using tree-based machine learning
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA299235-01

Date:	2025 - 2028
Title:	Characterizing symptom trajectories, predictors of symptoms, and relevant outcomes among survivors of breast cancer receiving endocrine therapy
Funding Source:	American Cancer Society (ACS)
Role:	Co-I
ID:	1308308

Date:	2024 - 2027
Title:	A population-based study of quality of life among advanced lung cancer survivors to establish parameters for a survivorship program
Funding Source:	Department of Defense (DOD)
Role:	mPI
ID:	GRANT13956195

Date:	2024 - 2025
Title:	Dyadic Yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers
Funding Source:	NIH/NCI
Role:	Co-I
ID:	4 R37CA231522

Date:	2024 - 2029
Title:	Systematic approach for managing secondary findings in clinical oncology practice
Funding Source:	NIH-OIR
Role:	mPI
ID:	1 R01CA292419-01

Date:	2024 - 2029
Title:	Identifying PF features most predictive of clinical outcomes in AYAs with cancer using machine learning algorithms
Funding Source:	NIH/NCI
Role:	Co-I
ID:	FP00012434_Res1

Date:	2024 - 2027
Title:	Assessing the experience and needs of advanced lung cancer survivors across Texas for the development of Survivorship Programs
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI
ID:	RP240218

Date:	2024 - 2026
Title:	Digital health to improve outcomes in women with cervical cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	1R21CA283021-01A1

Date:	2024 - 2027
Title:	MD Anderson ACCESS Hub for Cancer Screening and Early Detection
Funding Source:	NIH/NCI
Role:	Significant Contributor
ID:	1 UG1CA287023-01

Date:	2023 - 2025
Title:	Mobile symptom assessment for cervical cancer patients in Zambia
Funding Source:	NIH/NCI
Role:	PI
ID:	FP00020506

Date:	2023 - 2025
Title:	Early Breast Cancer Detection Using a Novel Plasmonic Nano-Aperture Label-Free Imaging (PANORAMA) Technique
Funding Source:	Breast Cancer Research Foundation
Role:	Co-I
ID:	2023BCRF00AAP0000248236

Date:	2023 - 2024
Title:	A Technological approach for performance status assessment in advanced cancer patients
Funding Source:	NIH/NCI
Role:	PI
ID:	3R01CA243554-04

Date:	2023 - 2026
Title:	Development of a PRO implementation toolkit for radiation oncology
Funding Source:	PROTEUS Consortium and Pfizer Global Medical Grants
Role:	Quality Improvement Specialist
ID:	N/A

Date:	2023 - 2028
Title:	Understanding the Needs of Advanced Lung Cancer Survivors
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	1R01CA281857-01

Date:	2023 - 2025
Title:	Digital health to improve outcomes in women with cervical cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	1R21CA283021-01

Date:	2023 - 2024
Title:	Previvors Recharge: A Resilience Program for Cancer Previvors
Funding Source:	NIH/NCI
Role:	Consult
ID:	1 R43CA275673-01A1

Date:	2023 - 2028
Title:	Systematic approach for managing secondary findings of genomic profiling in clinical practice
Funding Source:	NIH/NCI
Role:	MPI
ID:	1R01HG013018-01

Date:	2023 - 2028
Title:	MD Anderson Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program
Funding Source:	NIH/NCI
Role:	Research Mentor
ID:	1U54CA280881-01

Date:	2023 - 2025
Title:	Evaluating choice architecture-based interventions for cascade testing
Funding Source:	NIH/NCI
Role:	PI
ID:	1 R21 CA279315-01

Date:	2023 - 2028
Title:	Identifying functional features most predictive of clinical outcomes in AYAs with cancer using machine learning algorithms
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA278747-01

Date:	2022 - 2024
Title:	Incorporating implications of incidental germline findings discovered during tumor genomic profiling into clinical practice
Funding Source:	NIH/NCI
Role:	MPI
ID:	1R21CA277292-01

Date:	2022 - 2025
Title:	Creation of a Novel Rare Tumor Clinical Community and Web-Based Platform for Data Dissemination
Funding Source:	Department of Defense (DOD)
Role:	Co-I
ID:	RA210201

Date:	2022 - 2025
Title:	IGNITE-TX (Increase Genetic Hereditary Cancer Testing in Texas)
Funding Source:	CANCER PREVENTION RESEARCH INST OF TX
Role:	Collaborator
ID:	PP2220039

Date:	2022 - 2024
Title:	Digital phenotyping and machine learning approach for characterizing and predicting chemotherapy-related symptoms
Funding Source:	William Marsh Rice University
Role:	Co-I
ID:	FP00015764

Date:	2022 - 2027
Title:	Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy
Funding Source:	NIH/NIAID
Role:	Mentor, Advisory Committee Member
ID:	1 K01AI163412-01A1

Date:	2022 - 2027
Title:	Dosing and Rotating Opioids in Cancer Patients with Shortness of Breath
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA269600-01

Date:	2022 - 2027
Title:	Psycho-Spiritual Management for Patients with Advanced Cancer and their Spousal Caregivers
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA258640-01A1

Date:	2022 - 2025
Title:	Digital Health to Improve Outcomes in Women with Cervical Cancer
Funding Source:	Emerson Collective
Role:	PI
ID:	FP00014888

Date:	2022 - 2023
Title:	Feasibility of Technological Approaches for Improving Cancer Survivorship in Low and Middle-Income Countries (LMIC)s
Funding Source:	NIH/NCI
Role:	PI
ID:	FP00000298_Rev1

Date:	2022 - 2024
Title:	Identifying underserved individuals in Texas with hereditary cancer risk using mobile mammography units and telegenetics
Funding Source:	MD Anderson Quasi Endowment Committee Institutional grant
Role:	Collaborator
ID:	2022-00060886-Y1

Date:	2022 - 2027
Title:	Using wearables with personalized inference models to objectively evaluate the performance status of AYAs with cancer in real-life conditions
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01NR020318-01

Date:	2021 - 2025
Title:	A technology-enabled approach to enhancing outpatient symptom management
Funding Source:	Rising Tide Foundation
Role:	PI
ID:	CCR-21-500

Date:	2021 - 2026
Title:	There is No Place Like Home - A Pragmatic Effectiveness Trial of Technology-enhanced Outpatient Symptom Management
Funding Source:	NIH/NCI
Role:	Principle investigator (MPI)
ID:	1R01CA264989-01A1

Date:	2021 - 2025
Title:	Trajectories of adjustment in young adult cancer patient-caregiver dyads: A measurement burst study to examine short- and long-term change and variability
Funding Source:	Department of Defense (DOD)
Role:	Co-Career Guide
ID:	W81XWH-21-1-0184

Date:	2021 - 2024
Title:	Creation of a novel rare tumor clinical community and web-based platform for data dissemination from a medullary thyroid cancer registry
Funding Source:	Department of Defense (DOD)
Role:	Co-I
ID:	RA200402

Date:	2021 - 2024
Title:	CA201140: Leveraging electronic activity monitoring to assess performance status in Adolescent and Young Adult (AYA) cancer patients
Funding Source:	Department of Defense (DOD)
Role:	Career guide
ID:	FP00011784

Date:	2021 - 2024
Title:	IGNITE-TX (Increase Genetic Hereditary Cancer Testing in Texas)
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	PP210034

Date:	2021 - 2025
Title:	Incorporating implications of incidental germline findings discovered during tumor genomic profiling into clinical practice
Funding Source:	NIH/NCI
Role:	Multi-PI
ID:	R01 CA264169-01

Date:	2021 - 2026
Title:	There is no place like home- A Hybrid Effectiveness-Implementation Trial of Technology-enhanced Outpatient Symptom Management to Reduce Hospitalizations from Chemotherapy-related Adverse Events
Funding Source:	NIH/NCI
Role:	Multi-PI
ID:	1R01CA264989-01

Date:	2021 - 2026
Title:	Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy
Funding Source:	NATL INST ALLERGY & INFECTIOUS DISEASES
Role:	Advisory Committee Member
ID:	1K01AI163412-01

Date:	2021 - 2023
Title:	Addressing Financial Toxicity in Young Adult Cancer Survivors by Engaging Stakeholders in the Development of a Coping-Based Intervention
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R21CA261864-01

Date:	2021 - 2026
Title:	Psycho-Spiritual Management for Patients with Advanced Cancer and their Spousal Caregivers
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA258640-01

Date:	2021 - 2026
Title:	Modeling patient, healthcare provider-relationship and treatment factors in the dynamic adaptation to challenges in the initial period of daily oral pill in ER+ breast cancer patients
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA258991-01

Date:	2020 - 2025
Title:	Multilevel investigation of uncertain and reclassified genomic variants in clinical oncology
Funding Source:	NIH/NCI
Role:	Mentor
ID:	1K99CA256216-01

Date:	2020 - 2025
Title:	Optimizing communication of uncertainty in hereditary cancers using multimodal approaches
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	1U01CA254828-01

Date:	2020 - 2023
Title:	A Digital Intervention for Family Communication, Outreach, Networking and Education for Cancer GeneTic Risk (FamilyCONNECT)
Funding Source:	Radiant Creative Group, LLC
Role:	PI
ID:	1R44CA257731-01

Date:	2020 - 2023
Title:	Optimizing Patient-centered Survivorship Outcomes in Young-Onset Colorectal Cancer
Funding Source:	Colorectal Cancer Alliance
Role:	Collaborator
ID:	Not yet Available

Date:	2020 - 2022
Title:	There is no place like home- A Hybrid Effectiveness-Implementation Trial of Technology-enhanced Outpatient Symptom management to Reduce Acute Care Visits due to Chemotherapy-related Adverse Events
Funding Source:	Agency for Healthcare Research and Qual
Role:	Co-PI
ID:	FP00011391

Date:	2020 - 2021
Title:	COMBAT-COVID-19: Comprehensive Monitoring, Biomarkers, and Therapy Assessment study in cancer patients with known or suspected COVID-19 (SPORE Supplement)
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	CA70907

Date:	2020 - 2021
Title:	CCSG supplement: DCPPS Cannabis use among cancer patients and survivors: access, use patterns, knowledge, perceived risks and benefits; and interactions with healthcare providers
Funding Source:	NIH/NCI
Role:	Co-I
ID:	FP00002373_Rev9

Date:	2020 - 2021
Title:	CCSG supplement: DCPPS Developing and Implementing Financial Hardship Screening in Cancer Care Delivery
Funding Source:	NIH/NCI
Role:	Co-I
ID:	FP00002373_Rev12

Date:	2020 - 2021
Title:	COMBAT-COVID-19: Comprehensive Monitoring, Biomarkers, and Therapy Assessment study in cancer patients with known or suspected COVID-19
Funding Source:	University of Texas Southwestern Med Ctr - Dallas
Role:	PD/PI
ID:	FP00011558

Date:	2020 - 2025
Title:	Improving risk prediction for Li-Fraumeni Syndrome: A practical tool for clinical health care providers
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	RP200383

Date:	2020 - 2025
Title:	Patient engagement and genomic analysis in early-onset colorectal cancer
Funding Source:	City of Hope National Medical Center
Role:	PI
ID:	1U2CCA252970-01

Date:	2020 - 2025
Title:	Power up: participating online while exercising to recover using play
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1U01CA246675-01A1

Date:	2020 - 2025
Title:	Texas NORC: Linking obesity and nutrition research across Texas
Funding Source:	University of Texas Health Science Center-Houston
Role:	Collaborator
ID:	P30DK128565

Date:	2020 - 2025
Title:	Immune-Related Adverse Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitor Therapy
Funding Source:	National institute of Allergy and Infectious diseases
Role:	Co- Mentor
ID:	1K01AI149745-01A1

Date:	2020 - 2023
Title:	Engaging Providers in a Patient- Centered Intervention to Address Financial Toxicity of Breast Cancer Treatment
Funding Source:	Conquer Cancer Foundation
Role:	Collaborator
ID:	Not yet available

Date:	2020 - 2023
Title:	Improving communication in families with hereditary cancer via a collaborative family history data collection and intervention system
Funding Source:	Radiant Creative Group
Role:	PI
ID:	1R44CA247354-01A1

Date:	2020 - 2022
Title:	Differences in uninformative and reinterpreted genetic result management
Funding Source:	American Association for Cancer Research (AACR)
Role:	Mentor
ID:	Not yet available

Date:	2020 - 2022
Title:	There is no place like home- A Hybrid Effectiveness-Implementation Trial of Technology-enhanced Outpatient Symptom management to Reduce Acute Care Visits due to Chemotherapy-related Adverse Events
Funding Source:	Patient-Centered Outcomes Research Institute (PCORI)
Role:	Co-PI
ID:	FP00011189

Date:	2020 - 2022
Title:	Overcoming barriers in radiation oncology care delivery: Using a digital tool to improve financial toxicity management of patients with breast cancer
Funding Source:	American Society for Therapeutic Radiology and Oncology (ASTRO)
Role:	Other Significant Contributor
ID:	FP00010220

Date:	2020 - 2023
Title:	Magnified: Improving and realizing the cancer prevention impact of genetic knowledge
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	RP200260

Date:	2020 - 2026
Title:	A technological approach for performance status assessment in advanced cancer patients
Funding Source:	NIH/NCI
Role:	PI
ID:	5 R01CA243554

Date:	2020 - 2022
Title:	Media-Rich Mobile Dissemination of a Dysphagia Prevention Program for Head and Neck Cancer Patients during Radiation
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Evaluator
ID:	PP200045

Date:	2020 - 2022
Title:	Caregiver Psychological Stress and Quality of Life among Pediatric Brain Tumor Patients with Epilepsy
Funding Source:	Alex's Lemonade Stand Foundation
Role:	Other Significant Contributor
ID:	Not yet Available

Date:	2019 - 2024
Title:	Clinical, psychosocial and behavioral impact of variant of uncertain significance (VUS) reclassification in genomic testing for hereditary cancer
Funding Source:	NIH/NCI
Role:	Mentor
ID:	1K99CA245795-01

Date:	2019 - 2022
Title:	Career Development Skills for Junior Investigators Conducting Patient-Centered Outcomes Research in Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1 UE5 CA246748-01

Date:	2019 - 2020
Title:	Early detection of hereditary ovarian cancer through reclassification of genetic Variants of Uncertain Significance (VUS): Perspectives of clinical practitioners and clinical utility
Funding Source:	HERA Women’s Cancer Foundation
Role:	Mentor
ID:	FP00008751

Date:	2019 - 2023
Title:	A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management
Funding Source:	Food and Drug Administration (FDA)
Role:	Co-I
ID:	1R01FD006650-01

Date:	2019 - 2024
Title:	Non-pharmacologic Alternative Treatment of Chemotherapy-Induced Peripheral Neuropathy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01NR018838-01

Date:	2019 - 2024
Title:	Multi-Level Intervention for Delivery of Clinical Cancer Genetics Care: Building from Case Ascertainment to Follow-up Care
Funding Source:	NIH/NCI
Role:	PI
ID:	1U01CA232817-01A1

Date:	2019 - 2024
Title:	POWER UP: Participating Online While Exercising to Recover Using Play
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1U01CA246675-01

Date:	2019 - 2022
Title:	Improving communication in families with hereditary cancer via a collaborative family history data collection and intervention system
Funding Source:	Radiant Creative Group
Role:	PI
ID:	1U01CA232817-01A1

Date:	2019 - 2025
Title:	iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
Funding Source:	NIH/NCI
Role:	Co-I
ID:	UG1CA242609

Date:	2019 - 2022
Title:	Identifying individuals appropriate for genetic evaluation and testing for hereditary cancer susceptibility in primary care setting
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	PP190059

Date:	2019 - 2026
Title:	Cancer Center Support (CORE) Grant
Funding Source:	NIH/NCI
Role:	Co-I
ID:	P30CA016672 -47

Date:	2019 - 2024
Title:	HEALTH4Families: Optimizing a weight management and health behavior intervention for BRCA+ and Lynch syndrome families
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA243327-01

Date:	2019 - 2024
Title:	Impact of Predicted Tumoral Sensitivity on Simulated and Actual Adherence to Oral Endocrine Treatment and Breast Cancer Outcome
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1 R01 CA240810-01

Date:	2019 - 2024
Title:	Unobtrusive wireless sensing system for the early detection of persistent swallowing disfunction in head and neck cancer patients
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01DE028577-01

Date:	2019 - 2023
Title:	Standardized Modeling of Health Communication Constructs and Information Exposure within Online Interactions for Behavior Change
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2019 - 2021
Title:	Immune Related Toxicity and Symptom Burden In Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
Funding Source:	Division of Internal Medicine Research and Quality Improvement Development Awards
Role:	Co-I

Date:	2018 - 2022
Title:	Patient-Centered Outcomes in Chronic Cancer Survivors
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI
ID:	RP180732

Date:	2018 - 2021
Title:	Implementing genetic evaluation and testing services for hereditary breast and ovarian cancer in primary care setting
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-Project Director

Date:	2018 - 2023
Title:	Multi-Level Intervention for Delivery of Clinical Cancer Genetics Care: Building from Case Ascertainment to Follow-up Care
Funding Source:	NIH/NCI
Role:	Investigator

Date:	2018 - 2020
Title:	Facebook Intervention for Young Onset Melanoma Patients and Families
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01CA221854

Date:	2017 - 2020
Title:	Increasing Standard of Care Genetic Testing in BRCA1, 2 associated Hereditary Breast and Ovarian Cancer by Identifying High Risk Women from Texas Cancer Registry
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-Project Director

Date:	2017 - 2020
Title:	Outreach, Education and Navigation to Behavioral Counseling to Prevent Skin Cancer in Medically Underserved Communities
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I

Date:	2017 - 2021
Title:	Clinical trial participation among older breast cancer patients
Funding Source:	American Cancer Society (ACS)
Role:	Mentor

Date:	2017 - 2021
Title:	Clinical trial participation among older breast cancer patients
Funding Source:	American Cancer Society (ACS)
Role:	Co-I

Date:	2017 - 2018
Title:	Interactive web-based platform to rapidly disseminate evidence-based clinical knowledge in cancer genetics
Funding Source:	Diamond Tree LLC
Role:	PI

Date:	2017 - 2021
Title:	Decision Support for Genomic Sequencing in Academic and Community Setting
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	RFA-HG-16-010

Date:	2017 - 2022
Title:	Clinical and patient-reported natural history of medullary thyroid carcinoma for developing tools to inform use of drug therapies in advanced disease
Funding Source:	Food and Drug Administration (FDA)
Role:	Co-I

Date:	2017 - 2021
Title:	Economic Strain and Resilience: Novel Measures of Cancer Treatment Burden
Funding Source:	American Cancer Society (ACS)
Role:	Mentor

Date:	2016 - 2021
Title:	Economic Strain and Resilience in Cancer Patients: Assessing Patient-Reported Measures of the Burdens of Treatment
Funding Source:	NIH/NCI
Role:	Mentor
ID:	K07CA211804

Date:	2016 - 2017
Title:	CCSG Supplement - Pop Health Assessment in Catchment Areas
Funding Source:	NIH/NCI
Role:	Co-I
ID:	CA013372

Date:	2016 - 2022
Title:	Cancer Comparative Effectiveness in Texas (CERCIT)
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I
ID:	RP160674

Date:	2016 - 2017
Title:	HEALTH 4 Families: Optimizing weight management eHealth strategies for BRCA and Lynch syndrome families
Funding Source:	The Ardmore Institute for Health
Role:	Co-I

Date:	2016 - 2017
Title:	Economic Strain and Resilience in Underserved Cancer Patients
Funding Source:	CROR Center for Radiation Oncology Research
Role:	Co-I

Date:	2016 - 2023
Title:	Mobile, Social and Wearable Technology in Cancer Prevention and Survivorship
Funding Source:	NIH/NCI
Role:	PI
ID:	CA209986

Date:	2016 - 2021
Title:	Advancing CYCORE Technology in Cancer Research Management
Funding Source:	NIH/NCI
Role:	Co-I
ID:	000178

Date:	2016 - 2018
Title:	Economic Strain in Cancer Patients (Pilot Study)
Funding Source:	UT MD Anderson Cancer Center Institutional Research Grant
Role:	Co-I

Date:	2016 - 2021
Title:	Advanced development and dissemination of an integrated data processing system to improve physical activity assessment and interventions to prevent cancer and cancer recurrence
Funding Source:	NIH/NCI
Role:	PI

Date:	2016 - 2018
Title:	Assisting patients with radiation and surgery treatment Choices
Funding Source:	Andrew Sabin Family Fellowship Grant
Role:	Mentor
ID:	2016-00052270-Y1

Date:	2016 - 2021
Title:	ACUTE B Trial: Acute Uncomplicated Type B aortic dissection: endovascular repair vs best medical therapy
Funding Source:	PCORI
Role:	PI
ID:	TBD

Date:	2015 - 2021
Title:	Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors
Funding Source:	NIH/NCI
Role:	Multi PD/PI
ID:	R42CA168107

Date:	2015 - 2017
Title:	Increasing Communication and Outreach in Lynch Syndrome families
Funding Source:	NIH/NCI
Role:	PI

Date:	2015 - 2020
Title:	Adherence to Oral ET, Predicted Tumoral Sensitivity, and Breast Cancer Outcomes
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2015 - 2019
Title:	Media-rich Mobile Dissemination of a Dysphagia Prevention Program for Head and Neck Cancer Patients During Radiation
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I
ID:	PP150077

Date:	2015 - 2017
Title:	Evaluation of a Web-based Outreach Strategy for Lynch Syndrome Families
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I

Date:	2015 - 2020
Title:	Multifunctional Epidermal Sensing and Cyberinfrastructure Systems to Detect and Prevent Persistent Swallowing Dysfunction in Head and Neck Cancer Patients
Funding Source:	NIH/NIDCR
Role:	PI
ID:	1R01DE025010-01

Date:	2014 - 2019
Title:	NCI Community Oncology Research Program (NCORP) Research Base (UM1)
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2014 - 2019
Title:	Adherence to Oral ET, Predicted Tumoral Sensitivity, and Breast Cancer Outcomes
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2014 - 2019
Title:	NCI Community Oncology Research Program (NCORP) Research Bases (UM1)
Funding Source:	NIH
Role:	Program Leader

Date:	2014 - 2019
Title:	Communicating cancer recommendations to lower health literacy populations
Funding Source:	American Cancer Society (ACS)
Role:	Co-Mentor

Date:	2014 - 2020
Title:	CYCORE: Cyberinfrastructure for Cancer Comparative Effectiveness Research
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01CA177996

Date:	2013 - 2016
Title:	Contralateral Prophylactic Mastectomy and Breast Cancer: Clinical and Psychosocial Outcomes
Funding Source:	Patient-Centered Outcomes Research Institute
Role:	Co-I
ID:	CE-1304-6293

Date:	2013 - 2018
Title:	Sensor-assisted Prevention of Dehydration in Head and Neck Cancer Patients
Funding Source:	NIH/NCI
Role:	PI
ID:	R01CA177914

Date:	2013 - 2016
Title:	Appearance-focused Interventions to Reduce Tanning Behavior in College Students
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2013 - 2018
Title:	Patient-Centered Approach to Facilitate Management of Lynch Syndrome Cancer Risk
Funding Source:	NIH/NCI
Role:	Mentor
ID:	3530433

Date:	2013 - 2016
Title:	Preventing dehydration in irradiated cancer patients: A comparative effectiveness study
Funding Source:	Patient-Centered Outcomes Research Institute (PCORI)
Role:	PI

Date:	2013 - 2016
Title:	Continuous Smoking Home Monitoring System for Cancer Survivors Enrolled in Tobacco Treatment Program
Funding Source:	Patient-Centered Outcomes Research Institute (PCORI)
Role:	Co-I

Date:	2013 - 2017
Title:	Comprehensive Integration of Genomic Information in Managing Women's Cancers
Funding Source:	NHGRI/NIH
Role:	Co-Program Leader
ID:	1UM1HG007330-01

Date:	2012 - 2015
Title:	Media-rich mobile health dissemination strategies for targeted swallowing exercise programs in irradiated head and neck cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I
ID:	R-13-IIRA-1

Date:	2012 - 2015
Title:	Sensor-assisted prevention of dehydration in irradiated head and neck cancer patients
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	R-13-IIRA-1

Date:	2012 - 2015
Title:	Navigating Familial Cancer Risk: Expansion of Cancer Genetics and Prevention Services to Kindreds with Hereditary Colorectal Cancer Syndromes
Funding Source:	MD Anderson Cancer Center Duncan Family Institute Strategic Research Initiative
Role:	PI

Date:	2012 - 2014
Title:	A Professional Oncology Education Program to Improve Providers’ Competence for Identifying and Managing Persons at Increased Colorectal Cancer Risk
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI

Date:	2012 - 2015
Title:	Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors
Funding Source:	NIH/NCI
Role:	PI
ID:	R41 CA168107

Date:	2012 - 2015
Title:	Integrating Technology and Navigation to Improve Survivorship Care in Underserved Populations
Funding Source:	Cancer Survivorship Research Program
Role:	PI

Date:	2012 - 2015
Title:	FIT-FLU Screening, Programming in the Houston Metropolitan Area
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I

Date:	2012 - 2015
Title:	A Social Network Approach to Improve Genetic Risk Communication
Funding Source:	Duncan Family Institute for Cancer Prevention and Risk Assessment
Role:	PI

Date:	2011 - 2014
Title:	Returning Incidental Sequencing Results to Lung Cancer Families
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2011 - 2016
Title:	Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01CA140377

Date:	2011 - 2012
Title:	Subcontract Radiant Creative Group: My Family Garden: Improving communication in families with hereditary cancer
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	R41CA162699

Date:	2010 - 2013
Title:	A Decision Making Framework for Contralateral Prophylactic Mastectomy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R21 CA149803

Date:	2010 - 2012
Title:	Increasing Primary Care Providers' Competence for Identifying and Managing Persons at Increased Breast Cancer Risk: A Professional Oncology Prevention Program
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I

Date:	2010 - 2014
Title:	Adolescents' Long-Term Adaptation to Familial Cancer Risks
Funding Source:	National Cancer Institute/NIH
Role:	Co-I
ID:	R01 CA137625

Date:	2010 - 2015
Title:	MyFAP.org: A Multimedia Intervention for Adolescents and Young Adults with FAP
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R42CA126453

Date:	2009 - 2014
Title:	Optical Technologies and Molecular Imaging for Cervical Neoplasia
Funding Source:	National Cancer Institute/NIH
Role:	Co-I
ID:	2P01-82710-09 (Project 4)

Date:	2009 - 2013
Title:	CYCORE: CYberinfrastructure for Comparative effectiveness REsearch
Funding Source:	NIH/NCI
Role:	PI
ID:	UC2 CA148263

Date:	2009 - 2012
Title:	Administrative Supplement to: Interactive CD-ROM on Cancer Genetics for Hispanics
Funding Source:	National Human Genome Research Institute/NIH
Role:	PI
ID:	R01 HG003844-03S1

Date:	2009 - 2011
Title:	Developing Providers' Communication and Counseling Skills in Cancer Genetics Using Virtual Reality
Funding Source:	Institutional Research Grant UTMDACC
Role:	PI
ID:	IRG

Date:	2007 - 2009
Title:	Multimedia Intervention for Adolescents with FAP
Funding Source:	National Cancer Institute/NIH
Role:	Co-I
ID:	1R41-CA126453-01

Date:	2006 - 2012
Title:	Interactive CD-ROM on Cancer Genetics for Hispanics
Funding Source:	National Human Genome Research Institute/NIH
Role:	PI
ID:	R01 HG003844

Date:	2004 - 2010
Title:	Colorectal Cancer (CRC) Screening in First Degree Relatives of CRC Patients
Funding Source:	American Cancer Society (ACS)
Role:	PI
ID:	MRSGT-04-204-01-CPHPS

Date:	2004 - 2008
Title:	A Targeted, Family-Focused Intervention for Melanoma Prevention
Funding Source:	American Cancer Society (ACS)
Role:	Co-I
ID:	RSGPB-04-010-01-CPPB

Date:	2001 - 2002
Title:	Cancer Genetics Network Recruitment of Probands and Family Members
Funding Source:	National Cancer Institute/NIH
Role:	Co-I
ID:	U24-CA78142A

Date:	2000 - 2007
Title:	A Phase I/II Study of Celecoxib in Genotype-Positive, Phenotype-Negative Children with FAP
Funding Source:	National Cancer Institute/NIH
Role:	Co-I
ID:	N01 CN 05126-02

Date:	1999 - 2002
Title:	Computer education for breast cancer genetic testing
Funding Source:	National Human Genome Research Institute/NIH
Role:	Co-Investigator (Principal Investigator, Subcontract)
ID:	R01-CA-84770

Date:	1999 - 2001
Title:	Family process and communication issues in HNPCC genetic testing
Funding Source:	Human Cancer Genetics Development Award, University of Texas MD Anderson Cancer Center
Role:	Co-I

Date:	1998 - 2019
Title:	Cancer Center Support Grant (Core) Grant - Assessment, Intervention and Measurement (AIM) Core
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5P30CA016672

Date:	1998 - 2003
Title:	Texas Cancer Genetics Consortium
Funding Source:	National Cancer Institute/NIH
Role:	Co-I
ID:	U24 CA078142

Date:	1998 - 2008
Title:	Colon Cancer Screening for Cancer Patients' Families
Funding Source:	National Cancer Institute/NIH, Fox Chase Cancer Center
Role:	Co-I
ID:	5R01 CA075795 07

Date:	1998 - 2001
Title:	Psychosocial aspects of genetic testing for HNPCC
Funding Source:	National Human Genome Research Institute/NIH
Role:	Co-I
ID:	R01-HG/CA-1200-06

Date:	1997 - 1999
Title:	Oncology nurses' knowledge of genetics and genetic testing
Funding Source:	Oncology Nursing Foundation/Chiron Therapeutics
Role:	PI

Date:	1996 - 1997
Title:	An assessment of awareness and attitudes regarding genetic testing for hereditary breast and colon cancers among CIS callers
Funding Source:	Special Initiative Grant, Division of Cancer Prevention, University of Texas MD Anderson Cancer Center
Role:	PI

Title:	Colorectal Cancer Screening in Relatives of CRC Patients (Awarded, but declined by PI so that overlapping grant, MRSGT-04-204-01-CPHPS (ACS) could be funded)
Funding Source:	National Cancer Institute/NIH
Role:	PI
ID:	R03 CA108362

Title:	Colon Cancer Screening for Cancer Patients' Families
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01-CA075795

Title:	Prospective Endometrial Cancer Screening Trial for Women with Lynch Syndrome
Funding Source:	National Cancer Institute/NIH
Role:	Co-I
ID:	R01-CA129497

Title:	Integrating Patient’s Values into Decisions to Enroll in Phase I Oncology Trials
Funding Source:	NIH/NCI
Role:	Co-I
ID:	RC1-CA146079-01

Title:	Evaluation and Mitigation of Potential Harms Associated with Virtual Colonoscopy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	RC1-CA145941-01

Title:	Developing and validating a mobile phone-based patient-reported outcomes application for comparing generic and brand name drugs for cancer patients
Funding Source:	Food and Drug Administration (FDA)
Role:	Collaborator

Title:	Optimizing health behavior interventions for survivorship care settings
Funding Source:	Susan G. Komen Breast Cancer Foundation
Role:	Co-Mentor

Title:	Clinical trial participation among older breast cancer patients
Funding Source:	Susan G. Komen Breast Cancer Foundation
Role:	Co-Mentor

Selected Publications

Peer-Reviewed Articles

Elmehrath AO, Njala B, Sakala D, Nogueras-Gonzalez GM, Munsell MF, Lombe DC, Fundafunda S, Chitula M, Peterson S, Chiao EY, Msasdabwe S, Lin LL. Demographic and Social Determinants of HIV Status Among Women with Cervical Cancer in a Low-Resource Setting. Int J Gynecol Cancer 36(4):102867, 2026. e-Pub 2026. PMID: 41622077.
Jackson, I, Liao, K, Peterson, SK, Li, L, Zorzi, D, Holmes, HM, Chavez Mac Gregor, M, Giordano, SH. Late Effects of Chemotherapy on Patient-Reported Neuropathy, Balance Problems, and Fall Outcomes Among Older Breast Cancer Survivors. JCO Oncology Practice, 2026. e-Pub 2026. PMID: 41719492.
Eversole, EA, Cha, E, Alatrach, M, Marquez, C, Peek, A, Lin, LL, Lowenstein, LM, Peterson, SK, Swanson, DM, Liao, Z, Chen, A. Leveraging patient-reported outcomes for enhanced symptom management among thoracic radiation patients. JCO Oncology Practice 21:381, 2025. e-Pub 2025.
Eversole, EA, Cha, E, Al-Sharfeen, A, Chen, A, Marquez, C, Peek, A, Peterson, SK, Lowenstein, LM, Swanson, DM, Klopp, AH, Lin, LL. Patient-reported outcomes as a tool for enhanced symptom management in gynecologic radiation oncology. JCO Oncology Practice 21:388, 2025. e-Pub 2025.
Lee, C, Sukumar, J, Strong, LL, Peterson, SK, Arun, BK, Vilar Sanchez, E, Baum, ML, Basen-Engquist, KM. Optimization Of Mhealth Behavioral Intervention For Families With Hereditary Breast And Ovarian Cancers. Medicine and science in sports and exercise 57(10S):796, 2025. e-Pub 2025.
Manne SL, Kashy DA, Pagoto S, Peterson SK, Heckman CJ, Gallo J, Berger A, Buller DB, Kulik A, Frederick S, Pesanelli M. Engagement in and correlates of total cutaneous exams and skin self-exams among young melanoma survivors and their family. J Behav Med 48(5):834-847, 2025. e-Pub 2025. PMID: 40684394.
Lee CY, Gordon MJ, Markofski MM, LaVoy EC, Peterson SK, Li L, Fares S, Baum M, Pace M, Walsh D, Ferrajoli A, Basen-Engquist K. Optimization of mHealth behavioral interventions for patients with chronic lymphocytic leukemia: the HEALTH4CLL study. J Cancer Surviv 19(4):1325-1334, 2025. e-Pub 2025. PMID: 38472612.
Choi E, Berkman AM, Andersen CR, Salsman JM, Betts AC, Milam J, Miller KA, Peterson SK, Lu Q, Cheung CK, Ghazal LV, Livingston J, T Hildebrandt MA, Parsons SK, Freyer DR, Roth ME. Cancer Screening Uptake and Usual Source of Care Among Hispanic Survivors of Adolescent and Young Adult Cancer. J Adolesc Young Adult Oncol, 2025. PMID: 40712648.
Kim, R, Peña, J, Liao, K, Peterson, SK, Li, L, Zorzi, D, Holmes, HM, Chavez Mac Gregor, M, Giordano, SH. Self-reported cognitive function in older breast cancer survivors after chemotherapy treatment. Breast 81, 2025. e-Pub 2025. PMID: 40184733.
Cho D, Roth M, Peterson SK, Jennings K, Kim S, Weathers S, Ahmed S, Livingston J, Barcenas C, You Y, Milbury K. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study. JMIR Res Protoc 13, 2025. e-Pub 2025. PMID: 38652520.
Peterson SK, Mayo-Wilson LJ, Spigel L, Morgan I, Parker A. Health care experiences of individuals accessing or undergoing in vitro fertilization (IVF) in the U.S.:. Front Reprod Health 7:1490917, 2025. e-Pub 2025. PMID: 40017896.
Berkman # AM, # EC, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston J, Battle A, T Hildebrandt MA, Parsons SK, Roth ME. Excess risk of chronic health conditions in Black adolescent and young adult cancer survivors. J Cancer Surviv 18(6):1931-1940, 2024. e-Pub 2024. PMID: 37578615.
Dukhanin V, McDonald KM, Peterson SK, Gleason KT. Single-encounter elicitation framework for diagnostic excellence patient-reported measures:. PEC Innov 5:100357, 2024. e-Pub 2024. PMID: 39633901.
Brown K, Ponton M, Davidson E, Arun B, Volk RJ, Shete S, Peterson SK, Makhnoon S. What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open-ended survey responses. Cancer 130(22):3926-3934, 2024. e-Pub 2024. PMID: 38843377.
Shinn EH, Garden AS, Chen M, Basen-Engquist K, Fellman B, Hutcheson K, Morrison WH, Peterson S, Li L. Self-management intervention improves patient adherence to swallowing exercises during radiation for head and neck cancer. Head and Neck 46(11):2878-2889, 2024. e-Pub 2024. PMID: 38873861.
Gleason KT, Dukhanin V, Peterson SK, Gonzalez N, Austin JM, McDonald KM. Development and Psychometric Analysis of a Patient-Reported Measure of Diagnostic Excellence for Emergency and Urgent Care Settings. J Patient Saf 20(7):498-504, 2024. e-Pub 2024. PMID: 39194332.
Choi E, Berkman AM, Battle A, Betts AC, Salsman JM, Milam J, Andersen CR, Miller KA, Peterson SK, Lu Q, Cheung CK, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Psychological distress and mental health care utilization among Black survivors of adolescent and young adult cancer. Cancer 130(17):3011-3022, 2024. e-Pub 2024. PMID: 38676935.
Szabo Yamashita T, Williams-Perez SM, Ehsan S, Mulder M, Kronenfeld D, Huang CY, Zhao H, Merriman K, Peterson SK, Hu MI, Zafereo M, Sosa JA, Grubbs EG. The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?. Thyroid 34(9):1117-1125, 2024. e-Pub 2024. PMID: 38984944.
Choi E, Berkman AM, Andersen CR, Salsman JM, Betts AC, Milam J, Miller KA, Peterson SK, Lu Q, Cheung CK, Ghazal LV, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Psychological distress and mental health care utilization among lesbian, gay, and bisexual survivors of adolescent and young adult cancer. Support Care Cancer 32(9):585, 2024. e-Pub 2024. PMID: 39134915.
Berkman AM, Choi E, Salsman JM, Peterson SK, Cheung CK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Excess risk of chronic health conditions in Hispanic survivors of adolescent and young adult cancers. J Cancer Surviv 18(3):907-916, 2024. e-Pub 2024. PMID: 36750493.
Cho D, Roth M, Peterson SK, Jennings K, Kim S, Weathers S, Ahmed S, Livingston J, Barcenas C, You Y, Milbury K. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship:. JMIR Res Protoc 13(1):e53307, 2024. e-Pub 2024. PMID: 38652520.
Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Socioeconomic Status and Chronic Health Conditions in Asian Survivors of Adolescent and Young Adult Cancers. J Adolesc Young Adult Oncol 13(2):262-270, 2024. e-Pub 2024. PMID: 37594775.
Zhang S, Chou L, Swartz MD, Mehta HB, Goodwin JS, Kuo Y, Giordano SH, Tucker CA, Basen-Engquist KM, Lyons EJ, Downer B, Peterson SK, Cao T, Swartz MC. Association of Cancer Diagnosis with Disability Status among Older Survivors of Colorectal Cancer: A Population-Based Retrospective Cohort Study. Front Oncol 14, 2024. PMID: 38559557.
Diao K, Lei X, He W, Jagsi R, Giordano SH, Smith GL, Caudle A, Shen Y, Peterson SK, Smith BD. Racial and Ethnic Differences in Long-Term Adverse Radiotherapy Effects among Breast Cancer Survivors. Int J Radiat Oncol Biol Phys 118(3):626-631, 2024. e-Pub 2024. PMID: 37751792.
Shinn EH, Garden AS, Peterson SK, Leupi DJ, Chen M, Blau R, Becerra L, Rafeedi T, Ramirez J, Rodriquez D, VanFossen F, Zehner S, Mercier PP, Wang J, Hutcheson K, Hanna E, Lipomi DJ. Iterative Patient Testing of a Stimuli-Responsive Swallowing Activity Sensor to Promote Extended User Engagement During the First Year After Radiation: Multiphase Remote and In-Person Observational Cohort Study. JMIR Cancer 10:e47359, 2024. e-Pub 2024. PMID: 38416544.
Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Risk of Chronic Health Conditions in Lesbian, Gay, and Bisexual Survivors of Adolescent and Young Adult Cancers. Cancer 130(4):553-562, 2024. e-Pub 2024. PMID: 38044705.
Zhang, S, Chou, LN, Swartz, MD, Mehta, HB, Goodwin, JS, Kuo, YF, Giordano, SH, Tucker, CA, Basen-Engquist, KM, Lyons, EJ, Downer, B, Peterson, SK, Cao, T, Swartz, MC. Association of cancer diagnosis with disability status among older survivors of colorectal cancer. Frontiers in Oncology 14, 2024. e-Pub 2024. PMID: 38559557.
Yoder AK, Lakomy DS, Wu J, Andring LM, Corrigan KL, Fellman B, Jhingran A, Klopp AH, Colbert LE, Soliman PT, Frumovitz MM, Peterson SK, Lin LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. e-Pub 2024. PMID: 37914588.
Choi E, Berkman AM, Cheung CK, Betts AC, Salsman JM, Andersen CR, Ochoa-Dominguez CY, Miller K, Milam J, Shah A, Peterson SK, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer D, Roth ME. Psychological distress and mental health care utilization among Hispanic/Latino survivors of adolescent and young adult cancer. Psychooncology 32(12):1918-1929, 2023. e-Pub 2023. PMID: 37955581.
Diao K, Lei X, He W, Jagsi R, Giordano SH, Smith GL, Caudle A, Shen Y, Peterson SK, Smith BD. Patient-Reported Quality of Life after Breast Conserving Surgery with Radiotherapy versus Mastectomy and Reconstruction. Ann Surg 278(5):e1096-e1102, 2023. e-Pub 2023. PMID: 37232937.
Adesoye T, Liao KP, Peterson S, Li L, Zorzi D, Holmes HM, Chavez-MacGregor M, Giordano SH. Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment. Cancer Med 12(17):17740-17752, 2023. e-Pub 2023. PMID: 37551136.
Dohopolski MJ, Diao K, Hutcheson KA, Akhave NS, Goepfert RP, He W, Lei XJ, Peterson SK, Shen Y, Sumer BD, Smith BD, Sher DJ. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 149(8):697-707, 2023. e-Pub 2023. PMID: 37382943.
Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston J, Peterson SK, Parsons SK, Roth M. Association of Patient-Reported Health-Related Quality of Life with Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer. JCO Oncol Pract 19(8):610-619, 2023. e-Pub 2023. PMID: 37311165.
Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Roth M. Patient-reported quality of life in adolescents and young adults with cancer who received radiation therapy. Cancer Med 12(13):14157-14170, 2023. e-Pub 2023. PMID: 37199075.
Offodile AC, Delgado D, Lin YL, Geyen D, Miller CJ, Jain S, Finder JP, Shete S, Fossella FV, Overman MJ, Peterson SK. Integration of Remote Symptom and Biometric Monitoring into the Care of Adult Patients with Cancer Receiving Chemotherapy- A Decentralized Feasibility Pilot study. JCO Oncol Pract 19(6):OP2200676, 2023. e-Pub 2023. PMID: 36821818.
Williams LA, Whisenant MS, Mendoza TR, Peek AE, Malveaux D, Griffin DK, Ponce DA, Granwehr BP, Sheshadri A, Hutcheson KA, Ali SM, Peterson SK, Heymach JV, Cleeland CS, Subbiah IM. Measuring symptom burden in patients with cancer during a pandemic: The MD Anderson Symptom Inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes 7(1):48, 2023. e-Pub 2023. PMID: 37237077.
Diao, K, Lei, X, Smith, GL, Jagsi, R, Peterson, SK, Sumer, BD, Smith, B, Sher, DJ. Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors. International Journal of Radiation Oncology Biology Physics 116(1):142-153, 2023. e-Pub 2023. PMID: 36812043.
Berkman AM, Andersen CR, Hildebrandt MAT, Livingston JA, Green AL, Puthenpura V, Peterson SK, Milam J, Miller KA, Freyer DR, Roth ME. Risk of early death in adolescents and young adults with cancer: A population-based study. J Natl Cancer Inst 115(4):447-455, 2023. e-Pub 2023. PMID: 36682385.
Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Andring LM, Geng Y, Kouzy R, Livingston JA, Peterson SK, Bishop AJ, Smith GL, Gunther JR, Parsons SK, Roth M. Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: A scoping review. Support Care Cancer 31(4):230, 2023. e-Pub 2023. PMID: 36961516.
Smith-Graziani DJ, Parker PA, Peterson SK, Bedrosian I, Shen Y, Black DM, DeSnyder SM, Hunt KK, Dong W, Brewster AM. Prospective Study of Pain Outcomes Associated with Breast Surgery in Women with Nonhereditary Breast Cancer. Ann Surg 277(3):e617-e623, 2023. e-Pub 2023. PMID: 33938495.
Yoder AK, Lakomy DS, Wu J, Andring LM, Fellman B, Colbert LE, Jhingran A, Klopp AH, Soliman P, Peterson SK, Lin LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol) 35(2):e215-e226, 2023. e-Pub 2023. PMID: 36494250.
Makhnoon S, Levin B, Ensinger M, Mattie K, Volk RJ, Zhao Z, Mendoza T, Shete S, Samiian L, Grana G, Grainger A, Arun B, Shirts BH, Peterson SK. A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes. Cancer Med 12(3):2875-2884, 2023. e-Pub 2023. PMID: 36426404.
Manne, S, Pagoto, SL, Peterson, SK, Heckman, CJ, Kashy, DA, Berger, AC, Studts, C, Negrón, R, Buller, D, Paddock, LE, Gallo, J, Kulik, A, Frederick, S, Pesanelli, M, Domider, M, Grosso, M. Facebook Intervention for Young-Onset Melanoma Survivors and Families. JMIR Research Protocols 12, 2023. e-Pub 2023. PMID: 36692933.
Shi JJ, McGinnis GJ, Peterson SK, Taku N, Chen YS, Yu RK, Wu CF, Mendoza TR, Shete SS, Ma H, Volk RJ, Giordano SH, Shih YT, Nguyen DK, Kaiser KW, Smith GL. Pilot study of a Spanish language measure of financial toxicity in underserved Hispanic cancer patients with low English proficiency. Front Psychol 14:1188783, 2023. e-Pub 2023. PMID: 37492449.
Shi JJ, Maldonado JA, Wu CF, Peterson SK, Chen YS, Diao K, Volk RJ, Giordano SH, Shih YT, Kaiser K, Smith GL. Financial Toxicity in Cancer Patients and Subsequent Risk of Repeat Acute Care Utilization. Front Psychol 14:1209526, 2023. e-Pub 2023. PMID: 37663351.
Makhnoon S, Yu R, Peterson SK, Shete S. Clinical Cancer and Direct-to-Consumer Genetic Test Result-Sharing Behavior: Findings from HINTS 2020. J Pers Med 13(1), 2022. e-Pub 2022. PMID: 36675679.
Makhnoon S, Chen M, Levin B, Ensinger M, Mattie KD, Grana G, Shete S, Arun BK, Peterson SK. Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes. Cancer 128(20):3709-3717, 2022. e-Pub 2022. PMID: 35996941.
Lopez-Olivo MA, Foreman JT, Leung C, Lin HY, Westrich-Robertson T, Hofstetter C, des Bordes JKA, Lyddiatt A, Leong A, Willcockson IU, Peterson SK, Suarez-Almazor ME. A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis. Semin Arthritis Rheum 56:152072, 2022. e-Pub 2022. PMID: 35872394.
McDonnell GA, Peshkin BN, DeMarco TA, Peterson SK, Arun BK, Miesfeldt S, O'Neill SC, Schneider K, Garber J, Isaacs C, Luta G, Tercyak KP. Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk. Pediatrics 150(2), 2022. e-Pub 2022. PMID: 35859209.
Corrigan KL, Fu S, Chen YS, Kaiser K, Roth M, Peterson SK, Shih YT, Jagsi R, Giordano SH, Volk RJ, Yabroff KR, Banegas MP, Acquati C, Conti RM, Ma HY, Ku K, You YN, Smith GL. Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer 128(13):2455-2462, 2022. e-Pub 2022. PMID: 35417565.
Lakomy DS, Yoder AK, Wu J, Hernandez M, Ayoola-Adeola M, Jhingran A, Klopp A, Soliman P, Peterson SK, Lin LL. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors. Int J Gynecol Cancer 32(10):1266-1275, 2022. e-Pub 2022. PMID: 35680139.
Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF, Hoffman KE, Smith GL, Jagsi R, Peterson SK, Smith BD. Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surg 157(6):e220631, 2022. e-Pub 2022. PMID: 35416926.
Pande M, Peterson S, Lynch PM. Development and evaluation of an online, patient-driven, family outreach intervention to facilitate sharing of genetic risk information in families with Lynch syndrome. J Med Genet 59(6):589-596, 2022. e-Pub 2022. PMID: 34006620.
Morand M, Roth M, Peterson SK, Bednar EM, Ramdaney A, Livingston JA, Yarbrough A, Corredor J. Factors impacting adolescent and young adult cancer patients' decision to pursue genetic counseling and testing. Support Care Cancer 30(6):5481-5489, 2022. e-Pub 2022. PMID: 35306607.
Makhnoon S, Maki KG, Yu R, Peterson SK, Shete S. Are beliefs about the importance of genetics for cancer prevention and early detection associated with high risk cancer genetic testing in the U.S. Population?. Prev Med Rep 27:101781, 2022. e-Pub 2022. PMID: 35378849.
Offodile AC, DiBrito SR, Finder JP, Shete S, Jain S, Delgado DA, Miller CJ, Davidson E, Overman MJ, Peterson SK. Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study. BMJ Open 12(4):e057693, 2022. e-Pub 2022. PMID: 35383081.
Basen-Engquist K, Raber M, Strong LL, Schembre S, Li L, Arun B, Lu K, You N, Vilar E, Lynch P, Fares S, Peterson SK. Optimization of an mHealth lifestyle intervention for families with hereditary cancer syndromes: Study protocol for a multiphase optimization strategy feasibility study. Contemp Clin Trials 113:106662, 2022. e-Pub 2022. PMID: 34971795.
Sheshadri A, Makhnoon S, Alousi AM, Bashoura L, Andrade R, Miller CJ, Stolar KR, Arain MH, Noor L, Balagani A, Jain A, Blanco D, Ortiz A, Taylor MS, Stenzler A, Mehta R, Popat UR, Hosing C, Ost DE, Champlin RE, Dickey BF, Peterson SK. Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability. JMIR Form Res 6(2):e29393, 2022. e-Pub 2022. PMID: 35129455.
Arun BK, Peterson SK, Sweeney LE, Bluebond RD, Tidwell RSS, Makhnoon S, Kushwaha AC. Increasing Referral of At-Risk Women for Genetic Counseling and BRCA Testing Using a Screening Tool in a Community Breast Imaging Center. Cancer 128(1):94-102, 2022. e-Pub 2022. PMID: 34424535.
Phillips SA, Garden AS, Shinn EH, Beadle BM, Shete S, Baum G, Patrick K, Farcas E, Camero Garcia M, Peterson SK. Factors associated with adherence to remote patient monitoring during radiation treatment for head and neck cancer. J Clin Onc, 2022. e-Pub 2022.
Xu C, Smith GL, Chen YS, Checka CM, Giordano SH, Kaiser K, Lowenstein LM, Ma H, Mendoza TR, Peterson SK, Shih YT, Shete S, Tang C, Volk RJ, Sidey-Gibbons C. Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques. PLoS One 17(8):e0272804, 2022. e-Pub 2022. PMID: 36006909.
Shinn EH, Busch BE, Jasemi N, Lyman CA, Toole JT, Richman SC, Symmans WF, Chavez-MacGregor M, Peterson SK, Broderick G. Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer. Front Psychol 13:856813, 2022. e-Pub 2022. PMID: 35903747.
Maldonado JA, Fu S, Chen YS, Acquati C, Yabroff KR, Banegas MP, Chang S, Conti RM, Checka CM, Peterson SK, Advani P, Ku K, Jagsi R, Giordano SH, Volk RJ, Shih YT, Smith GL. Sensitivity of Psychosocial Distress Screening to Identify Cancer Patients at Risk for Financial Hardship During Care Delivery. JCO Oncol Pract 17(12):OP2001009, 2021. e-Pub 2021. PMID: 34043452.
Boyce-Fappiano D, Liao K, Miller C, Peterson SK, Elting LS, Guadagnolo BA. Greater preferences for death in hospital and mechanical ventilation at the end of life among non-whites recently diagnosed with cancer. Support Care Cancer 29(11):6555-6564, 2021. e-Pub 2021. PMID: 33913005.
Manne S, Kashy DA, Pagoto S, Peterson SK, Heckman CJ, Gallo J, Berger A, Buller DB, Kulik A, Frederick S, Pesanelli M. Family Attitudes and Communication about Sun Protection and Sun Protection Practices among Young Adult Melanoma Survivors and Their Family Members. J Health Commun 26(11):1-11, 2021. e-Pub 2021. PMID: 34844521.
Makhnoon S, Tran G, Levin B, Mattie KD, Dreyer B, Volk RJ, Grana G, Arun BK, Peterson SK. Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes. Cancer 127(19):3605-3613, 2021. e-Pub 2021. PMID: 34157779.
Offodile AC, Seitz AJ, Peterson SK. Digital Health Navigation: An Enabling Infrastructure for Optimizing and Integrating Virtual Care Into Oncology Practice. JCO Clin Cancer Inform 5:1151-1154, 2021. e-Pub 2021. PMID: 34843379.
Boyce-Fappiano D, Liao K, Miller C, Peterson SK, Elting L, Guadagnolo BA. Preferences for more aggressive end-of-life pharmacologic care among racial minorities in a large population-based cohort of cancer patients. J Pain Symptom Manage 62(3):482-491, 2021. e-Pub 2021. PMID: 33556498.
Pemmaraju N, Wilson NR, Clementi Doan T, Qiao W, Peterson SK, Zoeller V, Schorr A, Verstovsek S. Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era. Leuk Lymphoma 62(9):1-8, 2021. e-Pub 2021. PMID: 33749512.
Makhnoon S, Smith HS, Bednar EM, Bhatt A, Turner L, Arun B, Volk RJ, Peterson SK. Disclosure of familial implications of pathogenic variants in breast-cancer genes to patients: Opportunity for prompting family communication. J Community Genet 12(3):439-447, 2021. e-Pub 2021. PMID: 33481188.
Makhnoon S, Corredor J, Arun B, Bell D, Yarbrough A, Livingston JA, Peterson SK, Roth M. Impact of a genetic evaluation initiative to increase access to genetic services for adolescent and young adults at a tertiary cancer hospital. J Adolesc Young Adult Oncol 10(3):296-302, 2021. e-Pub 2021. PMID: 32830989.
Grant S, Liao K, Miller C, Peterson S, Elting L, Guadagnolo BA. Lower levels of trust in the medical profession among white, younger, and more educated individuals with cancer. Am J Clin Oncol 44(4):150-157, 2021. e-Pub 2021. PMID: 33653973.
Makhnoon S, Yu R, Cunningham SA, Peterson SK, Shete S. Factors Influencing Discussion of Cancer Genetic Testing with Health-Care Providers in a Population-Based Survey. Public Health Genomics 24(1):1-11, 2021. e-Pub 2021. PMID: 33887738.
Peterson SK, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Shinn EH, Martch SL, Beadle BM, Garden AS, Farcas E, Brandon Gunn G, Fuller CD, Morrison WH, Rosenthal DI, Phan J, Eng C, Cinciripini PM, Karam-Hage MA, Camero Garcia M, Patrick K. Feasibility of Mobile and Sensor Technology for Remote Monitoring in Cancer Care and Prevention. AMIA Annu Symp Proc 2021:979-988, 2021. e-Pub 2021. PMID: 35308916.
Makhnoon S, Mork M, Arun B, Volk RJ, Peterson SK. Perceptions of provider's epistemic authority in response to variant of uncertain significance-related recommendations. J Genet Couns 30(2):513-521, 2020. e-Pub 2020. PMID: 33090616.
Sheshadri A, Alousi A, Bashoura L, Stolar K, Baghaie S, Arain MH, Noor L, Balagani A, Jain A, Blanco D, Ortiz A, Peterson SK, Langhals R, Taylor M, Stenzler A, Mehta RS, Popat UR, Hosing C, Rondon G, Shen F, Li L, Cheng GS, Ost DE, Champlin RE, Dickey BF. Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients. Ann Am Thorac Soc 17(10):1329-1333, 2020. e-Pub 2020. PMID: 32614241.
des Bordes JKA, Foreman J, Westrich-Robertson T, Lopez-Olivo MA, Peterson SK, Hofstetter C, Lyddiatt A, Willcockson I, Leong A, Suarez-Almazor ME. Interactions and perceptions of patients with rheumatoid arthritis participating in an online support group. Clin Rheumatol 39(6):1775-1782, 2020. e-Pub 2020. PMID: 32006180.
D'Agostino TA, Brewster AM, Peterson SK, Bedrosian I, Parker PA. Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis. Transl Behav Med 10(2):347-354, 2020. e-Pub 2020. PMID: 30561744.
Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. Effect of surgeon factors on long-term patient-reported outcomes after breast-conserving therapy in older breast cancer survivors. Ann Surg Oncol 27(4):1013-1022, 2020. e-Pub 2020. PMID: 31916092.
Donato KM, Moore K, Parker WM, Peterson SK, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, You YN, Burton-Chase AM. Health and lifestyle behaviors in colorectal cancer survivors with and without Lynch syndrome. J Community Genet 11(1):1-5, 2020. e-Pub 2020. PMID: 31016603.
Mittendorf KF, Hunter JE, Schneider JL, Shuster E, Rope AF, Zepp J, Gilmore MJ, Muessig KR, Davis JV, Kauffman TL, Bergen KM, Wiesner GL, Acheson LS, Peterson SK, Syngal S, Reiss JA, Goddard KAB. Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study. Mittendorf et al. Hereditary Cancer in Clinical Practice 17(31), 2019. e-Pub 2019.
Shinn EH, Jensen K, McLaughlin J, Garden AS, Fellman BM, Liang L, Peterson SK. Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation. Internet Interv 18:100289, 2019. e-Pub 2019. PMID: 31890636.
Clarke EV, Muessig KR, Zepp J, Hunter JE, Syngal S, Acheson LS, Wiesner GL, Peterson SK, Bergen KM, Shuster E, Davis JV, Schneider JL, Kauffman TL, Gilmore MJ, Reiss JA, Rope AF, Cook JE, Goddard KAB. Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting. Familial Cancer 18(3):317-325, 2019. e-Pub 2019. PMID: 30729418.
Tercyak KP, Bronheim SM, Kahn N, Robertson HA, Anthony BJ, Mays D, O'Neill SC, Peterson SK, Miesfeldt S, Peshkin BN, DeMarco TA. Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: A qualitative investigation of impact on children’s genetic health literacy and psychosocial adjustment. Transl Behav Med 9(3):493-503, 2019. e-Pub 2019. PMID: 31094441.
Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK. Women's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol 152(3):514-521, 2019. e-Pub 2019. PMID: 30876497.
Cunningham SA, Yu R, Shih T, Giordano S, McNeill LH, Rechis R, Peterson SK, Cinciripini P, Foxhall L, Hawk E, Shete S. Cancer-Related Risk Perceptions and Beliefs in Texas: Findings from a 2018 Population-Level Survey. Cancer Epidemiol Biomarkers Prev 28(3):486-494, 2019. e-Pub 2019. PMID: 30700446.
Cunningham SA, Yu R, Tina Shih YC, Giordano S, McNeill LH, Rechis R, Peterson SK, Cinciripini PM, Foxhall LE, Hawk ET, Shete S. Perceived Cancer-related Risk and Beliefs in Texas: Findings from a 2018 Population-Level Survey. Cancer Epidemiol Biomarkers Prev 28(3):486-494, 2019. e-Pub 2019. PMID: 30700446.
Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S, Peterson SK, You YN, Buchanan DD, Figueiredo JC, Campbell PT, Gallinger S, Newcomb PA, Potter JD, Lindor NM, Le Marchand L, Haile RW, Hopper JL, Jenkins MA, Basen-Engquist KM, Lynch PM, Pande M. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer 143(9):2250-2260, 2018. e-Pub 2018. PMID: 29904935.
Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM. Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol 36(25):2630-2638, 2018. e-Pub 2018. PMID: 30044695.
Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL, Waguespack SG, Perrier ND, Grubbs EG. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol 25(5):1395-1402, 2018. e-Pub 2018. PMID: 29427212.
Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study. Int J Radiat Oncol Biol Phys 100(4):882-890, 2018. e-Pub 2018. PMID: 29485067.
Schneider JL, Goddard KAB, Muessig KR, Davis JV, Rope AF, Hunter JE, Peterson SK, Acheson LS, Syngal S, Wiesner GL, Reiss JA. Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews. Hered Cancer Clin Pract 16:11, 2018. e-Pub 2018. PMID: 29760830.
Peterson SK, Garden AS, Shinn EH, Shete S, Martch SL, Camero M, Baum G, Farcas E, Lin K, RaabF, Nandigam V, Yan Y, Ferrarotto R, Godino J, Patrick K, Beadle BM. Using mobile and sensor technology to identify early dehydration risk in head and neck cancer patients undergoing radiation treatment: Impact on symptoms. Journal of Clinical Oncology 36(15_Suppl):6063-6063, 2018. e-Pub 2018.
Schvartsman G, Gutierrez-Barrera AM, Song J, Ueno NT, Peterson SK, Arun B. Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes. Cancer Med 6(11):2515-2522, 2017. e-Pub 2017. PMID: 29024537.
Tsai GJ, Cameron CA, Czerwinski JL, Mendez-Figueroa H, Peterson SK, Noblin SJ. Attitudes Towards Prenatal Genetic Counseling, Prenatal Genetic Testing, and Termination of Pregnancy among Southeast and East Asian Women in the United States. J Genet Couns 26(5):1041-1058, 2017. e-Pub 2017. PMID: 28251433.
Hunter JE, Arnold KA, Cook JE, Zepp J, Gilmore MJ, Rope AF, Davis JV, Bergen KM, Esterberg E, Muessig KR, Peterson SK, Syngal S, Acheson L, Wiesner G, Reiss J, Goddard KAB. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Fam Cancer 16(3):377-387, 2017. e-Pub 2017. PMID: 28176204.
Katz LH, Advani S, Burton-Chase AM, Fellman B, Polivka KM, Yuan Y, Lynch PM, Peterson SK. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency. Fam Cancer 16(2):231-237, 2017. e-Pub 2017. PMID: 27832499.
Ross J, Bojadzieva J, Peterson S, Noblin SJ, Yzquierdo R, Askins N, Strong L. The Psychosocial Effects of the Li-Fraumeni Education and Early Detection (LEAD) Program on Individuals with Li-Fraumeni Syndrome. Genetics in Medicine 19(9):1064-1070, 2017. e-Pub 2017. PMID: 28301458.
Burton-Chase AM, Parker WM, Polivka KM, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, You Y, Peterson SK. A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers. Cancer Med 6(3):698-707, 2017. e-Pub 2017. PMID: 28211618.
Hovick SR, Bevers TB, Vidrine JI, Kim S, Dailey PM, Jones LA, Peterson SK. User perceptions and reactions to an online cancer risk assessment tool: A process evaluation of Cancer Risk Check. J Cancer Educ 32(1):141-147, 2017. e-Pub 2017. PMID: 26546305.
Tripp MK, Gershenwald JE, Davies MA, Garcia J, Gritz ER, Hawk ET, Peterson SK. Assessment of Compliance With Texas Legislation Banning Indoor UV Tanning by Minors. JAMA Dermatol 153(2):228-229, 2017. e-Pub 2017. PMID: 27829081.
Burton-Chase AM, Parker WM, Donato KM, McCormick S, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, Nancy You Y, Peterson SK. Health-related quality of life in colorectal cancer survivors: are there differences between sporadic and hereditary patients?. J Patient Rep Outcomes 2(1):21, 2017. e-Pub 2017. PMID: 29757305.
Davies KR, Brewster AM, Bedrosian I, Parker PA, Crosby MA, Peterson SK, Shen Y, Volk RJ, Cantor SB. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033). Breast Cancer Res 18(1):93, 2016. e-Pub 2016. PMID: 27650678.
Lowery JT, Ahnen DJ, Schroy PC, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer 122(17):2633-45, 2016. e-Pub 2016. PMID: 27258162.
Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Lee JE, Gershenwald JE, Gritz ER. Correlates of Sun Protection and Sunburn in Children of Melanoma Survivors. Am J Prev Med 51(3):e77-85, 2016. e-Pub 2016. PMID: 27067306.
Streff H, Profato J, Ye Y, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. Cancer Incidence in First and Second Degree Relatives of BRCA1 and BRCA2 Mutation Carriers. Oncologist 21(7):869-74, 2016. e-Pub 2016. PMID: 27306910.
Rogith D, Yusuf RA, Hovick SR, Fellman BM, Peterson SK, Burton-Chase AM, Li Y, Bernstam EV, Meric-Bernstam F. Patient knowledge and information-seeking about personalized cancer therapy. Int J Med Inform 88:52-7, 2016. e-Pub 2016. PMID: 26878762.
Katz LH, Burton-Chase AM, Advani S, Fellman B, Polivka KM, Yuan Y, Lynch PM, Peterson SK. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. Clin Genet 89(3):392-8, 2016. e-Pub 2016. PMID: 26272410.
Schneider JL, Davis J, Kauffman TL, Reiss JA, McGinley C, Arnold K, Zepp J, Gilmore M, Muessig KR, Syngal S, Acheson L, Wiesner GL, Peterson SK, Goddard KA. Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators. Genet Med 18(2):152-61, 2016. e-Pub 2016. PMID: 25880440.
Parker PA, Peterson SK, Bedrosian I, Crosby MA, Shen Y, Black DM, Babiera G, Kuerer HM, Ying J, Dong W, Cantor SB, Brewster AM. Prospective study of surgical decision-making processes for contralateral prophylactic mastectomy in women with breast cancer. Ann Surg 263(1):178-83, 2016. e-Pub 2016. PMID: 25822675.
Thompson S, Noblin SJ, Lemons J, Peterson SK, Carreno C, Harbison A. Perceptions of Latinas on the Traditional Prenatal Genetic Counseling Model. J Genet Couns 24(4):675-82, 2015. e-Pub 2015. PMID: 25475921.
Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 121(2):269-75, 2015. e-Pub 2015. PMID: 25224030.
Yusuf RA, Rogith D, Hovick SR, Peterson SK, Burton-Chase AM, Fellman BM, Li Y, McKinney C, Bernstam EV, Meric-Bernstam F. Attitudes toward molecular testing for personalized cancer therapy. Cancer 121(2):243-50, 2015. e-Pub 2015. PMID: 25209923.
Hovick SR, Yamasaki JS, Burton-Chase AM, Peterson SK. Patterns of family health history communication among older African American adults. J Health Commun 20(1):80-7, 2015. e-Pub 2015. PMID: 25174859.
Rogith D, Yusuf RA, Hovick SR, Peterson SK, Burton-Chase AM, Li Y, Meric-Bernstam F, Bernstam EV. Attitudes regarding privacy of genomic information in personalized cancer therapy. J Am Med Inform Assoc 21(e2):e320-5, 2014. e-Pub 2014. PMID: 24737606.
Deshmukh AA, Cantor SB, Crosby MA, Dong W, Shen Y, Bedrosian I, Peterson SK, Parker PA, Brewster AM. Cost of Contralateral Prophylactic Mastectomy. Ann Surg Oncol 21(9):2823-30, 2014. e-Pub 2014. PMID: 24809301.
Burton-Chase AM, Hovick SR, Sun CC, Boyd-Rogers S, Lynch PM, Lu KH, Peterson SK. Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome. Clin Genet 86(2):185-9, 2014. e-Pub 2014. PMID: 23906188.
Woodson AH, Muse KI, Lin H, Jackson M, Mattair DN, Schover L, Woodard T, McKenzie L, Theriault RL, Hortobágyi GN, Arun B, Peterson SK, Profato J, Litton JK. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis. Oncologist 19(8):797-804, 2014. e-Pub 2014. PMID: 24951607.
Graves KD, Sinicrope PS, Esplen MJ, Peterson SK, Patten CA, Lowery J, Sinicrope FA, Nigon SK, Borgen J, Gorin SS, Keogh LA, Lindor NM, Family Registry BWGOTCC. Communication of genetic test results to family and health care providers following disclosure of research results. Genet Med 16(4):294-301, 2014. e-Pub 2014. PMID: 24091800.
Lynch HT, Snyder C, Stacey M, Olson B, Peterson SK, Buxbaum S, Shaw T, Lynch PM. Communication and technology in genetic counseling for familial cancer. Clin Genet 85(3):213-22, 2014. e-Pub 2014. PMID: 24355094.
Bannon SA, Mork M, Vilar E, Peterson SK, Lu K, Lynch PM, Rodriguez-Bigas MA, You YN. Patient-reported disease knowledge and educational needs in Lynch syndrome: Findings of an interactive multidisciplinary patient conference. Hered Cancer Clin Pract 12(1):1, 2014. e-Pub 2014. PMID: 24499499.
Peterson SK, Shinn EH, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Baru C, Krueger IH, Farcas E, Rios P, Garden AS, Beadle BM, Lin K, Yan Y, Martch SL, Patrick K. Identifying early dehydration risk with home-based sensors during radiation treatment: a feasibility study on patients with head and neck cancer. J Natl Cancer Inst Monogr 2013(47):162-8, 2013. e-Pub 2013. PMID: 24395986.
Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Urbauer DL, Fellman BM, Lee JE, Gershenwald JE. Randomized controlled trial of a sun protection intervention for children of melanoma survivors. Cancer Epidemiol Biomarkers Prev 22(10):1813-1814, 2013. e-Pub 2013. PMID: 24097199.
Carter RD, Raia M, Ewing-Cobbs L, Gambello M, Hashmi SS, Peterson SK, Robbins-Furman P, Potocki L. Stress and well-being among parents of children with Potocki Lupski syndrome. J Genet Couns 22(5):633-642, 2013. e-Pub 2013. PMID: 23709095.
Burton-Chase AM, Hovick SR, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families. Clin Genet 83(3):215-20, 2013. e-Pub 2013. PMID: 23414081.
Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 118(22):5637-43, 2012. e-Pub 2012. PMID: 22517269.
Ready K, Arun BK, Schmeler KM, Uyei A, Litton JK, Lu KH, Sun CC, Peterson SK. Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center. Fam Cancer 10(4):673-9, 2011. e-Pub 2011. PMID: 21681553.
Seth SG, Goka T, Harbison A, Hollier L, Peterson S, Ramondetta L, Noblin SJ. Exploring the role of religiosity and spirituality in amniocentesis decision-making among Latinas. J Genet Couns 20(6):660-73, 2011. e-Pub 2011. PMID: 21695589.
Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, Lacour RA, Johnson KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC. Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer 117(12):2659-67, 2011. e-Pub 2011. PMID: 21656744.
Patrick K, Wolszon L, Basen-Engquist KM, Demark-Wahnefried W, Prokhorov AV, Barrera S, Baru C, Farcas E, Krueger I, Palmer D, Raab F, Rios P, Ziftci C, Peterson SK. CYberinfrastructure for COmpaRative Effectiveness Research (CYCORE): Improving data from cancer clinical trials. Transl Behav Med 1(1):83-88, 2011. e-Pub 2011. PMID: 21516142.
Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract 7(1):43-7, 2011. e-Pub 2011. PMID: 21532810.
Palmquist AE, Koehly LM, Peterson SK, Shegog M, Vernon SW, Gritz ER. "The cancer bond": exploring the formation of cancer risk perception in families with Lynch syndrome. J Genet Couns 19(5):473-86, 2010. e-Pub 2010. PMID: 20401527.
Ready KJ, Daniels MS, Sun CC, Peterson SK, Northrup H, Lu KH. Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome. J Cancer Educ 25(3):401-4, 2010. e-Pub 2010. PMID: 20186516.
Burton AM, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER. Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control 21(4):513-21, 2010. e-Pub 2010. PMID: 20012181.
Manne SL, Coups EJ, Winkel G, Markowitz A, Meropol NJ, Lesko SM, Jacobsen PB, Haller D, Jandorf L, Peterson SK. Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer. Health Educ Res 24(5):897-908, 2009. e-Pub 2009. PMID: 19654222.
Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK. Perception of screening and risk-reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer 115(8):1598-1604, 2009. e-Pub 2009. PMID: 19280625.
Manne SL, Coups EJ, Markowitz A, Meropol NJ, Haller D, Jacobsen PB, Jandorf L, Peterson SK, Lesko S, Pilipshen S, Winkel G. A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann Behav Med 37(2):207–217, 2009. e-Pub 2009. PMID: 19418107.
Peterson SK, Pentz RD, Marani SK, Ward PA, Blanco AM, LaRue D, Vogel K, Solomon T, Strong LC. Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni Syndrome. Psychooncology 17(8):783-9, 2008. e-Pub 2008. PMID: 18688785.
Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH. Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer 113(2):326-35, 2008. e-Pub 2008. PMID: 18506736.
Lewis MJ, Peterson SK. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women. Community Genet 10(2):72-81, 2007. e-Pub 2007. PMID: 17380056.
Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: A single-institution study. Cancer 107(12):2745-51, 2006. e-Pub 2006. PMID: 17109443.
Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol 108(3 Pt 1):515-20, 2006. e-Pub 2006. PMID: 16946209.
Peterson SK, Pentz RD, Blanco AM, Ward PA, Watts BG, Marani SK, James LC, Strong LC. Evaluation of a decision aid for families considering p53 genetic counseling and testing. Genet Med 8(4):226-33, 2006. e-Pub 2006. PMID: 16617243.
Johnson C, Peterson SK, Turley JP, Ensor J, Amos C, Spitz M, Levin B, Berry D. Strategies to improve healthcare websites. AMIA Annu Symp Proc:969, 2006. e-Pub 2006. PMID: 17238588.
Peterson SK. The role of the family in genetic testing: Theoretical perspectives, current knowledge, and future directions. Health Educ Behav 32(5):627-39, 2005. e-Pub 2005. PMID: 16148209.
Green MJ, Peterson SK, Baker MW, Friedman LC, Harper GR, Rubinstein WS, Peters JA, Mauger DT. Use of an educational computer program before genetic counseling for breast cancer susceptibility: Effects on duration and content of counseling sessions. Genet Med 7(4):221-9, 2005. e-Pub 2005. PMID: 15834239.
Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 23(9):1902-10, 2005. e-Pub 2005. PMID: 15774782.
Pentz RD, Peterson SK, Watts B, Vernon SW, Lynch PM, Koehly LM, Gritz ER. Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information. Genet Test 9(3):261-8, 2005. e-Pub 2005. PMID: 16225406.
Johnson C, Ensor J, Amos C, Spitz M, Peterson S, Levin B, Berry DA. An informatics tool to assess colon cancer risk. AMIA Annu Symp Proc 2005:998, 2005. e-Pub 2005. PMID: 16779285.
Green MJ, Peterson SK, Baker MW, Harper GR, Friedman LC, Rubinstein WS, Mauger DT. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. JAMA 292(4):442-52, 2004. e-Pub 2004. PMID: 15280342.
Byrd TL, Peterson SK, Chavez R, Heckert A. Cervical cancer screening beliefs among young Hispanic women. Prev Med 38(2):192-7, 2004. e-Pub 2004. PMID: 14715211.
Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK, Gritz ER. How families communicate about HNPCC genetic testing: Findings from a qualitative study. Am J Med Genet C Semin Med Genet 119C(1):78-86, 2003. e-Pub 2003. PMID: 12704641.
Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, Gritz ER. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 12(4):304-13, 2003. e-Pub 2003. PMID: 12692104.
Kohlmann WK, Peterson SK. Psychosocial issues, genetic counseling, and testing for hereditary colon cancer. Primary Psychiatry 9:44-49, 2002. e-Pub 2002.
Byrd TL, VanDerslice J, Peterson SK. Attitudes and beliefs about environmental hazards in three diverse communities in Texas on the border with Mexico. Rev Panam Salud Publica 9((3)(3):154-60, 2001. e-Pub 2001. PMID: 11349350.
Peterson SK, Rieger PT, Marani SK, deMoor C, Gritz ER. Oncology nurses' knowledge, practice, and educational needs regarding cancer genetics. Am J Med Genet 98(1):3-12, 2001. e-Pub 2001. PMID: 11426452.
Vernon SW, Gritz ER, Peterson SK, Perz CA, Marani S, Amos CI, Baile WF. Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev 8(4 Pt 2):353-60, 1999. e-Pub 1999. PMID: 10207640.
Gritz, ER, Vernon SW, Peterson SK, Baile WF, Lynch PM, Amos CI, Frazier ML. Distress in the cancer patient and its association with genetic testing and counseling for hereditary non-polyposis colon cancer. Cancer Research, Therapy and Control 8:35-50, 1999. e-Pub 1999.
Vernon SW, Gritz ER, Peterson SK, Amos CI, Baile WF, Perz CA, Lynch PM. Design and methodology of a study of psychosocial aspects of genetic testing for hereditary colorectal cancer. Ann N Y Acad Sci 833:190-4, 1997. e-Pub 1997. PMID: 9616754.
Vernon SW, Gritz ER, Peterson SK, Amos CI, Perz CA, Baile WF, Lynch PM. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol 16(1):73-86, 1997. e-Pub 1997. PMID: 9028817.
Byrd TL, VanDerslice J, Peterson SK. Variation in environmental risk perceptions and information sources among three communities in El Paso, Texas. Risk: Health, Safety and Environment 8:355-372, 1997. e-Pub 1997.
Judkins AF, Peterson SK. Singletary SE. Satisfaction of breast cancer patients with a nonphysician-provider model of long-term follow-up care. Breast Disease 8:1-6, 1996. e-Pub 1996.
Peterson SK, Michas MM, Villejo LA. Evaluation of a learning resource center for cancer patients. Health Education Research 4:495-500, 1989. e-Pub 1989.

Invited Articles

Burton AM, Hovick SR, Peterson SK. Health behaviors in patients and families with hereditary colorectal cancer. Clin Colon Rectal Surg 25(2):111-117, 2012. e-Pub 2012. PMID: 23730226.
Pruitt SL, Parker PA, Peterson SK, Le T, Follen M, Basen-Engquist K. Knowledge of cervical dysplasia and human papillomavirus among women seen in a colposcopy clinic. Gynecol Oncol 99(3 Suppl 1):S236-44, 2005. e-Pub 2005. PMID: 16150483.
Kohlmann WK, Peterson SK. Medical management and genetic counseling issues in hereditary non-polyposis colon cancer and familial adenomatous polyposis. Nurse Investigator 6(2), 2004. e-Pub 2004.
Peterson SK, Vernon SW. A review of patient and physician adherence to colorectal cancer screening guidelines. Seminars in Colon and Rectal Surgery 11:58-72, 2000. e-Pub 2000.

Review Articles

Lee, KL, Msadabwe-Chikuni, SC, Lombe, DC, Nogueras Gonzalez, G, Krishnamani, P, Carriere, P, Huang, A, Sichizya, L, Chiao, EY, Krause, KJ, Lin, LL, Peterson, SK. Use of Interactive, Patient-Centric Mobile Health Technology in Sub-Saharan Africa. JCO Glob Oncol 11, 2025. e-Pub 2025. PMID: 40768687.
Christopherson U, Wells SJ, Parker N, Lyons EJ, Swartz MD, Blozinski A, Basen-Engquist K, Peterson S, Swartz MC. Use of active video games with or without videoconferencing on health outcomes in adolescent and young adult cancer survivors: a systematic review. J Cancer Surviv 16(4):714-727, 2022. e-Pub 2022. PMID: 34086184.
Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA. Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis. Clin Genet 100(2):119-131, 2021. e-Pub 2021. PMID: 33843052.
Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC, Arun B, You Y, Rodriguez-Bigas MA, Strong LL, Lu KH, Basen-Engquist K. Diet, weight management, physical activity and Ovarian & Breast Cancer Risk in women with BRCA1/2 pathogenic Germline gene variants:. Hered Cancer Clin Pract 18:5, 2020. e-Pub 2020. PMID: 32165993.
Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC, Pande M, Vilar E, You Y, Rodriguez-Bigas MA, Strong LL, Lynch PM, Lu KH, Basen-Engquist K. Energy balance related lifestyles factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: systematic review. Fam Cancer 18(4):399-420, 2019. e-Pub 2019. PMID: 31236808.
Liao Y, Thompson C, Peterson S, Mandrola J, Beg MS. The Future of Wearable Technologies and Remote Monitoring in Health Care. Am Soc Clin Oncol Educ Book 39:115-121, 2019. e-Pub 2019. PMID: 31099626.
Blanchard P, Volk RJ, Ringash J, Peterson SK, Hutcheson KA, Frank SJ. Assessing head and neck cancer patient preferences and expectations: A systematic review. Oral Oncol 62:44-53, 2016. e-Pub 2016. PMID: 27865371.
Hughes C, Peterson SK, Ramirez A, Gallion KJ, McDonald PG, Skinner CS, Bowen D. Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 13(7):1146-55, 2004. e-Pub 2004. PMID: 15247125.

Abstracts

Peterson S, Strong L, Schembre S, Cox M, Li L, Karam C, Song J, Arun B, Pande M, You Y, Rodriguez-Bigas M, Lu K, Lynch P, Basen-Engquist K. Health4Families: An intervention to improve weight and health behaviors in families with hereditary breast/ovarian cancer or Lynch syndrome. Journal of Clinical Oncology 35(#1555), 2017. e-Pub 2017.
Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Giordano SH, Hunt KK, Pusic AL, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Population-Based Assessment of Patient-Reported Cosmetic Outcomes in Older Breast Cancer Survivors. Int J Radiat Oncol Biol Phys 96(2S):E14, 2016. e-Pub 2016. PMID: 27673881.
I Muse K, Bednar E, Emborgo TS, Oakley HD, Litton JK, Peterson SK, Lu KH, Arun AB. Universal BRCA testing of TNBC and HGSOC and active family outreach increases identification of at-risk relatives for cascade testing. 2016 ASCO Annual Meeting I, 2016. e-Pub 2016.
Strom MB, Cox M, Song J, Karam C, Peterson SK, Basen-Engquist K. Feasibility of a multi-component intervention for health education in cancer prevention, 2015. e-Pub 2015.
Peterson SK, Burton-Chase AM, Galvan C, McLaughlin J, Yzquierdo R, Askins M. Peterson SK, Burton-Chase AM, Galvan C, McLaughlin J, Yzquierdo R, Askins M. Facilitating family genetic risk communication in Lynch syndrome: The potential role of E-health technology. Annals of Behavioral Medicine 47(Supplement):s247, 2014. e-Pub 2014.
Parker PA, Peterson SK, Bedrosian I, Crosby M, Cantor SB, Ying J, Shen Y, Volk RJ, Brewster AM. Psychosocial characteristics of women with sporadic unilateral breast cancer considering contralateral prophylactic mastectomy (CPM). Annals of Behavioral Medicine 47(Supplement):s5, 2014. e-Pub 2014.
Galvan C, Burton-Chase AM, Askins M, McLaughlin J, Yzquierdo R, Peterson SK. Internet health information sources for hereditary colorectal cancer and their perceived trustworthiness. Annals of Behavioral Medicine 47(Supplement):s193, 2014. e-Pub 2014.
Peterson SK, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Shinn EH, Martch SL, Farcas E, Baru C, Krueger IH, Garden AS, Beadle BM, Eng C, Cinciripini PM, Karam-Hage MA, Gunn GB, Fuller CD, Morrison WH, Rosenthal DI, Phan J, Patrick K. Feasibility of using home-based mobile sensors for remote patient monitoring in cancer care and prevention. Journal of Clinical Oncology 32(5s)(Supplement), 2014. e-Pub 2014.
Pentz RD, Liu Y, Wall L, Daugherty C, Green MJ, Hlubocky FJ, Peterson SK, Sun CC, Dixon M, Harvey R, Owonikoko TK, Khuri FR. Physicians’ ability to correctly identify values important to cancer patients enrolled in phase I clinical trials. 2012 ASCO Annual Meeting. e-Pub 2012.
Peterson S, Basen-Engquist K, Denmark-Wahnefried W, Prokhorov A, Baru C, Farcas E, Krueger I, Palmer D, Raab F, Rios P, Barrera S, Wolszon L, Patrick K. CYCORE: A CYberinfrastructure to support COmparative effectiveness REsearch in behavioral medicine. Annals of Behavioral Medicine 41(Supplement):s53, 2011. e-Pub 2011.
Sun CC, Peterson SK, White KG, Watts BG, Daniels MS, Boyd-Rogers SG, Schmeler KM, Bodurka DC, Lu KH. Preferences for cancer prevention strategies in women with hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology 24(18S):53s, 2006. e-Pub 2006.
Johnson CM, Peterson SK, Turley JP, Ensor J, Amos C, Spitz M, Levin B, Berry D. Strategies to improve healthcare websites. AMIA Annual Symposium Proceedings:969, 2006. e-Pub 2006. PMID: 17238588.
Lu KH, Watts BG, Soliman PT, Boyd-Roger, SG, Daniels MS, Broaddus RR, Lynch PM, Peterson SK. A prospective pilot study of combined colon and endometrial cancer screening in women with HNPCC. Familial Cancer 4(S1):104, 2005. e-Pub 2005.
Peterson SK, Askins MA, Watts BG, Burke CA, Hasson H, Church J, Schover L, Hawk E, Lynch PM. Family resiliency and functioning among families with APC-positive children. Familial Cancer 4(S1):49, 2005. e-Pub 2005.
Peterson SK, Gritz ER, Vernon SW, Perz CA, Marani SK, Watts BG, Amos CI, Frazier M, Lynch PM. Colonoscopy utilization before and after HNPCC genetic testing. American Journal of Human Genetics 73(S5):240, 2003. e-Pub 2003.
Peterson SK, Watts BG, Askins M, Schover LR, Michelson SJ, Chandler G, Lynch PM. Psychosocial assessment of children and parents involved in a Phase I pilot study of celecoxib in children with familial adenomatous polyposis. Familial Cancer 2(S1):61, 2003. e-Pub 2003.
Green MJ, Peterson SK, Wagner Baker M, Friedman LC, Harper GR, Rubinstein WS, Mauger D. Can a computer replace genetic counseling for BRCA1/2 genetic testing?. American Journal of Human Genetics 73(S5):174, 2003. e-Pub 2003.
Peterson SK, Watts BG, Lynch PM, Vernon SW, Kapoor S, Gritz ER. Family characteristics associated with nonreferral of relatives for HNPCC genetic counseling and testing. American Journal of Human Genetics 71(S4):239, 2002. e-Pub 2002.
Gritz, ER, Peterson SK, Vernon SW, Marani SK, Watts BG, Ward PA, Kohlmann WK, Frazier ML, Amos CI, Lynch PM. Psychosocial impact of HNPCC genetic counseling and testing. Journal of Law, Medicine and Ethics 29:19, 2001. e-Pub 2001.
Peterson, SK, Rieger PT, Marani SK. Oncology nurses' attitudes regarding ethical issues in cancer genetics. Journal of Law, Medicine and Ethics 29:51, 2001. e-Pub 2001.
Vernon, SW, Peterson SK, Gritz ER, Perz CA, Watts BG, Marani SK, Baile WF, Amos CI, Lynch PM. Psychosocial characteristics of colorectal cancer patients at different medical risk of colorectal cancer. Journal of Law, Medicine and Ethics 29:18, 2001. e-Pub 2001.
Ortman, A, Pentz R, Ward P, Hecht J, Peterson SK, Johnston D, Amos C. Development and evaluation of an educational videotape about inherited cancer predisposition. Journal of Genetic Counseling 9:492, 2000. e-Pub 2000.
Tew, SJ, Ward PA, Peterson SK, Hecht JM, Johnston DA, Gritz ER. A qualitative approach to assessing patient satisfaction with the cancer genetic counseling process. Journal of Genetic Counseling 8:385-386, 1999. e-Pub 1999.
Peterson, SK, Gritz ER, Vernon SW, Marani SK, Rieger PT, Ward PA, Mills GB. Genetic counseling and testing for hereditary breast/ovarian cancer: The impact of receiving positive and uninformative results. American Journal of Human Genetics 65:A316, 1999. e-Pub 1999.
Rieger, PT, Peterson SK. The ON-GENES Study: Oncology nurses' knowledge of genetics and genetic testing. Oncology Nursing Forum 26:225, 1999. e-Pub 1999.
Peterson SK, Vernon SW, Ward JA, Marani SK. Anticipated uptake of cancer genetic testing among Cancer Information Service callers. Medical Decision Making 17(4):529, 1997. e-Pub 1997.
Lynch PM, Mork M, Bonnon SA, Peterson SK. A structured web-based family outreach approach for communicating genetic cancer risk in extended families with Lynch syndrome.

Book Chapters

Makhnoon S, Peterson SK. Psychosocial issues in genetic testing for hereditary colorectal cancer. In: Psycho-oncology. Oxford University Press, Inc, 2021.
Peterson SK, Patrick, K. Creating a Health Information Technology Infrastructure to Support Comparative Effectiveness Research in Cancer. In: Oncology Informatics, 2016.
Patenaude A, Peterson SK. Psychosocial issues in genetic testing for hereditary colorectal cancer. In: Psycho-oncology. 3rd. Oxford University Press, Inc, 2015.
Burton AM, Gritz ER, Peterson SK. Genetic Counseling and Testing for Hereditary Cancers: Psychosocial Considerations. In: AAPI Clinical Manual of Psycho-Oncology. American Psychiatric Publishing, 145-169, 2013.
Peterson SK. Psychological Impact of Genetic Counseling and Testing for Hereditary Colorectal Cancers. In: Hereditary Colorectal Cancer. Springer Publication, 559-573, 2010.
Patenaude A, Peterson SK. Psychosocial Issues in Genetic Testing for Hereditary Colorectal Cancer. In: Psycho-oncology. 2nd. Oxford University Press, Inc, 110-115, 2010.
Peterson SK. Psychological Impact of Genetic Counseling and Testing for Hereditary Gynecologic Cancers. In: Hereditary Gynecological Cancer: Risk, Prevention and Management. Informa Healthcare USA, 261-278, 2008.

Less

CV information above last modified September 01, 2026

Susan K Peterson, Ph.D., M.P.H.

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Abstracts

Book Chapters

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Susan K Peterson, Ph.D., M.P.H.

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Abstracts

Book Chapters

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson